Processing 00000000.tx.1: Abnormalities of Retinal Metabolism in Diabetes and Experimental Galactosemia VII. 

Phrase: "Abnormalities of Retinal Metabolism"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   819   C0035300:Retinal abnormalities [Finding]
   770   C0000768:Abnormalities [Congenital Abnormality]
   770   C0000769:abnormalities [Functional Concept]
   737 E C1704258:Abnormality [Finding]

Phrase: "in Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "Experimental Galactosemia VII."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0445385:VII [Intellectual Product]
Processing 00000000.tx.2: Effect of Long-Term Administration of Antioxidants on the Development of Retinopathy Renu A. 

Phrase: "Effect of Long-Term Administration of Antioxidants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0023983:Long-Term Effect [Phenomenon or Process]
   757   C3179302:Antioxidant Effect [Physiologic Function]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on the Development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of Retinopathy Renu A."
Processing 00000000.tx.3: Kowluru1, Jie Tang2, and Timothy S. 

Phrase: "Kowluru1,"

Phrase: "Jie Tang2,"

Phrase: "and"

Phrase: "Timothy S."
Processing 00000000.tx.4: Kern2 1 Kresge Eye Institute, Wayne State University, Detroit, Michigan, and the 2 Department of Medicine, Case Western Reserve University, Cleveland, Ohio  ABSTRACT TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Antioxidants were administered to diabetic rats and experimentally galactosemic rats to evaluate the ability of these agents to inhibit the development of diabetic retinopathy. 

Phrase: "Kern2 1 Kresge Eye Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0021622:institute [Organization]
   804   C1272753:Institute [Idea or Concept]

Phrase: "Wayne State University,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0041740:University [Manufactured Object,Organization]
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]

Phrase: "Detroit,"

Phrase: "Michigan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025939:Michigan [Geographic Area]

Phrase: "and"

Phrase: "the 2 Department of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "Case Western Reserve University,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0041740:University [Manufactured Object,Organization]
   812   C0868928:Case [Functional Concept]
   812   C1705493:Western [Spatial Concept]
   812   C1706255:CASE [Medical Device]
   812   C1706256:Case [Conceptual Entity]
   812   C2347957:Reserve [Activity]

Phrase: "Cleveland,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454845:Cleveland [Geographic Area]

Phrase: "Ohio  ABSTRACT TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C0035171:Research Design [Research Activity]
   795   C0035168:research [Research Activity]
   795   C0242481:Research [Research Activity]
   795   C1707689:Design [Activity]
   795   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Antioxidants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003402:Antioxidants [Pharmacologic Substance]

Phrase: "were"

Phrase: "administered to diabetic rats"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C0241863:DIABETIC [Finding]
   770   C1521801:Administered [Functional Concept]
   737 E C1621583:Administer [Functional Concept]

Phrase: "and"

Phrase: "experimentally galactosemic rats to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the ability of these agents to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the development of diabetic retinopathy."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]
Processing 00000000.tx.5: Alloxan diabetic rats and nondiabetic rats that were fed 30% galactose randomly received standard diets or the diets supplemented with ascorbic acid and -tocopherol (vitamins C+E diet) or a more comprehensive mixture of antioxidants (multi-antioxidant diet), including Trolox, -tocopherol, N-acetyl cysteine, ascorbic acid, -carotene, and selenium. 

Phrase: "Alloxan diabetic rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "and"

Phrase: "nondiabetic rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "that"

Phrase: "were"

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "30% galactose randomly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016945:Galactose [Biologically Active Substance,Carbohydrate]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "standard diets"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0012155:Diets [Food]
   861   C1442989:Standard [Qualitative Concept]
   861   C2828392:Standard [Intellectual Product]
   827 E C1442959:Diet [Organism Function]
   827 E C1519433:DIET [Therapeutic or Preventive Procedure]
   827 E C2983588:DIET [Food]
   777 E C2699635:DIETARY [Functional Concept]

Phrase: "or"

Phrase: "the diets"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0012155:Diets [Food]
   966 E C1442959:Diet [Organism Function]
   966 E C1519433:DIET [Therapeutic or Preventive Procedure]
   966 E C2983588:DIET [Food]
   916 E C2699635:DIETARY [Functional Concept]

Phrase: "supplemented with ascorbic acid"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   833   C0003968:Ascorbic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   823   C3661608:Vitamin C supplement [Food]
   777 E C0699147:Cecon [Carbohydrate,Pharmacologic Substance,Vitamin]
   777 E C0699151:Cenolate [Carbohydrate,Pharmacologic Substance,Vitamin]
   777 E C0699153:Cevalin [Carbohydrate,Pharmacologic Substance,Vitamin]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   750 E C2349136:Vitamin C [Organic Chemical,Vitamin]
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]

Phrase: "and -"

Phrase: "tocopherol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0087096:Tocopherol [Lipid,Pharmacologic Substance,Vitamin]
  1000   C3255108:Tocopherol [Pharmacologic Substance]

Phrase: "(vitamins C+E diet"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0012155:Diet [Food]
   812   C1442959:Diet [Organism Function]
   812   C1519433:DIET [Therapeutic or Preventive Procedure]
   812   C2983588:DIET [Food]
   741 E C2699635:DIETARY [Functional Concept]

Phrase: ")"

Phrase: "or"

Phrase: "a more comprehensive mixture of antioxidants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439962:Mixture [Substance]

Phrase: "(multi-antioxidant diet"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0012155:Diet [Food]
   827   C1442959:Diet [Organism Function]
   827   C1519433:DIET [Therapeutic or Preventive Procedure]
   827   C2983588:DIET [Food]
   755 E C2699635:DIETARY [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Trolox, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0147003:Trolox [Organic Chemical,Pharmacologic Substance]

Phrase: "tocopherol,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0087096:Tocopherol [Lipid,Pharmacologic Substance,Vitamin]
  1000   C3255108:Tocopherol [Pharmacologic Substance]

Phrase: "N-acetyl cysteine,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0001047:N-Acetyl Cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   845 E C0699252:Mucomyst [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "ascorbic acid, -"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0003968:Ascorbic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   944 E C0699147:Cecon [Carbohydrate,Pharmacologic Substance,Vitamin]
   944 E C0699151:Cenolate [Carbohydrate,Pharmacologic Substance,Vitamin]
   944 E C0699153:Cevalin [Carbohydrate,Pharmacologic Substance,Vitamin]
   916 E C2349136:Vitamin C [Organic Chemical,Vitamin]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "carotene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007269:Carotene [Biologically Active Substance,Organic Chemical]

Phrase: "and"

Phrase: "selenium."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036581:Selenium [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
  1000   C2348282:Selenium [Element, Ion, or Isotope]
Processing 00000000.tx.6: Diabetes or galactose feeding of at least 12 months resulted in pericyte loss, acellular capillaries, and basement membrane thickening. 

Phrase: "Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "or"

Phrase: "galactose feeding of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0204695:Feeding [Health Care Activity]
   790   C2987508:Feeding [Activity]

Phrase: "at least 12 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439231:months [Temporal Concept]
   793 E C0439507:/month [Temporal Concept]

Phrase: "resulted in pericyte loss,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0598800:Pericyte [Cell]
   770   C1517945:Loss [Quantitative Concept]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "acellular capillaries,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0006901:Capillaries [Body Part, Organ, or Organ Component]
   861   C0935624:Capillaries [Body Part, Organ, or Organ Component]
   827 E C1280521:Capillary [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "basement membrane thickening."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0544995:Basement membrane thickening [Cell or Molecular Dysfunction]
   901   C0004799:Basement membrane [Tissue]
   827   C0025255:Membrane [Tissue]
   827   C0205400:Thickening [Finding]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   827   C1979853:Basement [Cell Component]
   755 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.7: Compared with diabetic controls, the development of acellular capillaries was inhibited by 50% (P < 0.05) in diabetic rats that received supplemental vitamins C+E, and the number of pericyte ghosts tended to be reduced. 

Phrase: "Compared with diabetic controls,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0241863:DIABETIC [Finding]
   770   C1707455:Compared [Activity]
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]

Phrase: "the development of acellular capillaries"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]

Phrase: "was"

Phrase: "inhibited by 50%"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   790   C0311403:Inhibited [Qualitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "that"

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "supplemental vitamins C+E,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0042874:Vitamin E [Lipid,Pharmacologic Substance,Vitamin]
   844   C0003968:Vitamin C [Organic Chemical,Pharmacologic Substance,Vitamin]
   844   C2349136:Vitamin C [Organic Chemical,Vitamin]

Phrase: "and"

Phrase: "the number of pericyte ghosts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "tended"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "reduced."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]
Processing 00000000.tx.8: The vitamins C+E supplement had no beneficial effect in galactosemic rats, but these rats consumed only approximately half as much of the antioxidants as the diabetic rats. 

Phrase: "The vitamins C+E supplement"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   912   C3661607:Vitamin E supplement [Food]
   912   C3661608:Vitamin C supplement [Food]
   886   C0681579:Vitamin supplement [Food]
   812   C0242295:Supplement [Food]
   812   C1947943:Supplement [Intellectual Product]
   812   C2348609:Supplement [Functional Concept]

Phrase: "had"

Phrase: "no beneficial effect in galactosemic rats,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "but"

Phrase: "these rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "consumed"

Phrase: "only approximately half"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205171:Only [Quantitative Concept]
   827   C0332232:Approximately [Qualitative Concept]
   827   C1720467:Only [Intellectual Product]
   827   C2825407:Half [Quantitative Concept]

Phrase: "as"

Phrase: "much of the antioxidants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0003402:Antioxidants [Pharmacologic Substance]

Phrase: "as the diabetic rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]
Processing 00000000.tx.9: The multi-antioxidant diet significantly inhibited (5565%) formation of both pericyte ghosts and acellular capillaries in diabetic rats and galactosemic rats (P < 0.05 vs. controls), without affecting the severity of hyperglycemia. 

Phrase: "The multi-antioxidant diet significantly"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0012155:Diet [Food]
   812   C1442959:Diet [Organism Function]
   812   C1519433:DIET [Therapeutic or Preventive Procedure]
   812   C2983588:DIET [Food]
   741 E C2699635:DIETARY [Functional Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "(5565%"

Phrase: ")"

Phrase: "formation of both pericyte ghosts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "acellular capillaries in diabetic rats"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0006901:Capillaries [Body Part, Organ, or Organ Component]
   760   C0935624:Capillaries [Body Part, Organ, or Organ Component]
   726 E C1280521:Capillary [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "galactosemic rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "without affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the severity of hyperglycemia."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0239979:HYPERGLYCEMIA, SEVERE [Finding]
   770   C0439793:Severity [Qualitative Concept]
   770   C2983285:Severity [Intellectual Product]
Processing 00000000.tx.10: Parameters of retinal oxidative stress, protein kinase C activity, and nitric oxides remained elevated for at least 1 year of hyperglycemia, and these abnormalities were normalized by multi-antioxidant therapy. 

Phrase: "Parameters of retinal oxidative stress,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0449381:Parameters [Finding]
   726 E C0549193:Parameter [Spatial Concept]
   726 E C1704769:Parameter [Conceptual Entity]
   726 E C2350001:Parameter [Quantitative Concept]

Phrase: "protein kinase C activity,"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
  1000   C1150572:protein kinase C activity [Molecular Function]
   923   C1150527:protein kinase activity [Molecular Function]
   923   C3642159:Protein C Activity [Laboratory Procedure]
   905 E C2261495:protein phosphokinase activity [Molecular Function]
   902   C1537044:protein activity [Molecular Function]
   875   C1150423:kinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   708   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   708   C1168438:Protein C [Laboratory Procedure]
   708   C1418943:PROTEIN C [Gene or Genome]
   708   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "nitric oxides"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0028128:nitric oxides [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:Oxides [Inorganic Chemical]
   827 E C2986642:oxide [Chemical Viewed Functionally]

Phrase: "remained"

Phrase: "elevated for"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0205250:Elevated [Qualitative Concept]
   833   C3163633:Elevated [Qualitative Concept]

Phrase: "at least 1 year"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439234:year [Temporal Concept]
   827   C0439508:/year [Temporal Concept]

Phrase: "of hyperglycemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "and"

Phrase: "these abnormalities"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0000768:Abnormalities [Congenital Abnormality]
  1000   C0000769:abnormalities [Functional Concept]
   966 E C1704258:Abnormality [Finding]
   916 E C0205161:Abnormal [Qualitative Concept]
   916 E C2347472:% Abnormal [Quantitative Concept]
   916 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "were"

Phrase: "normalized by multi-antioxidant therapy."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0003402:Antioxidant [Pharmacologic Substance]
   760   C0039798:therapy [Functional Concept]
   760   C0087111:Therapy [Therapeutic or Preventive Procedure]
   760   C0439064:Multi [Quantitative Concept]
   760   C1363945:Therapy [Finding]
   760   C1882115:Normalized [Research Activity]
Processing 00000000.tx.11: Thus, long-term administration of antioxidants can inhibit the development of the early stages of diabetic retinopathy, and the mechanism by which this action occurs warrants further investigation. 

Phrase: "Thus,"

Phrase: "long-term administration of antioxidants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0001554:Administration [Occupational Activity]
   760   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "can"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the development of the early stages of diabetic retinopathy,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0243107:development [Physiologic Function]
   742   C0678723:Development [Organism Function]
   742   C1527148:Development [Functional Concept]
   726   C0870411:Developmental stages [Temporal Concept]

Phrase: "and"

Phrase: "the mechanism by which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "this action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441472:Action [Functional Concept]
  1000   C3266814:Action [Activity]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "warrants further investigation."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C1261322:Investigation [Health Care Activity]
   827   C1552578:investigation [Idea or Concept]
   755 E C1517586:Investigational [Qualitative Concept]
   755 E C3245491:investigational [Intellectual Product]
Processing 00000000.tx.12: Supplementation with antioxidants can offer an achievable and inexpensive adjunct therapy to help inhibit the development of retinopathy in diabetes.  

Phrase: "Supplementation with antioxidants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0242297:Supplementation [Therapeutic or Preventive Procedure]

Phrase: "can"

Phrase: "offer"

Phrase: "an achievable"

Phrase: "and"

Phrase: "inexpensive adjunct therapy to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0677850:adjunct therapy [Therapeutic or Preventive Procedure]
   812   C0039798:therapy [Functional Concept]
   812   C0087111:Therapy [Therapeutic or Preventive Procedure]
   812   C1363945:Therapy [Finding]

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the development of retinopathy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]

Phrase: "in diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.13: INTRODUCTION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Hyperglycemia induces metabolic disorders that initiate a sequence of events that lead to the development of retinopathy. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "metabolic disorders"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025517:METABOLIC DISORDERS [Disease or Syndrome]
   861   C0012634:Disorders [Disease or Syndrome]

Phrase: "that"

Phrase: "initiate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "a sequence of events"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C1519249:Sequence [Functional Concept]

Phrase: "that"

Phrase: "lead to the development of retinopathy."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0035309:Retinopathy [Disease or Syndrome]
   753   C0243107:development [Physiologic Function]
   753   C0678723:Development [Organism Function]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C1527148:Development [Functional Concept]
   753   C1962966:Retinopathy [Finding]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.14: This is illustrated convincingly by the evidence that nondiabetic animals in which blood hexose concentration is increased with a galactose-rich diet develop retinal capillary lesions that are indistinguishable from those that develop in diabetic humans or animals (1,2,3,4). 

Phrase: "This"

Phrase: "is"

Phrase: "illustrated"

Phrase: "convincingly by the evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "that nondiabetic animals in which blood hexose concentration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0003062:Animals [Animal]

Phrase: "is"

Phrase: "increased with a galactose-rich diet"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   783   C1291102:Increased galactose [Finding]
   753   C0012155:Diet [Food]
   753   C0016945:Galactose [Biologically Active Substance,Carbohydrate]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0699759:Rich [Qualitative Concept]
   753   C1442959:Diet [Organism Function]
   753   C1519433:DIET [Therapeutic or Preventive Procedure]
   753   C2983588:DIET [Food]

Phrase: "develop"

Phrase: "retinal capillary"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006901:Capillary [Body Part, Organ, or Organ Component]
   861   C0935624:Capillary [Body Part, Organ, or Organ Component]
   861   C1280521:Capillary [Body Part, Organ, or Organ Component]

Phrase: "lesions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221198:Lesion [Finding]
  1000   C1546698:Lesion [Intellectual Product]

Phrase: "that"

Phrase: "are"

Phrase: "indistinguishable from those"

Phrase: "that"

Phrase: "develop in diabetic humans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086418:Humans [Human]
   770   C0241863:DIABETIC [Finding]

Phrase: "or"

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.15: Multiple hypotheses have proposed how hyperglycemia might cause the development of retinopathy (5,6,7,8,9,10,11), but it has been difficult to recognize which abnormalities are critical. 

Phrase: "Multiple hypotheses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512571:Hypothesis [Idea or Concept]

Phrase: "have"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "how hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "might"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "the development of retinopathy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6,"

Phrase: "7,"

Phrase: "8,"

Phrase: "9,"

Phrase: "10,"

Phrase: "11"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "recognize"

Phrase: "which abnormalities"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0000768:Abnormalities [Congenital Abnormality]
  1000   C0000769:abnormalities [Functional Concept]
   966 E C1704258:Abnormality [Finding]
   916 E C0205161:Abnormal [Qualitative Concept]
   916 E C2347472:% Abnormal [Quantitative Concept]
   916 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "are"

Phrase: "critical."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511545:Critical [Qualitative Concept]
Processing 00000000.tx.16: Diabetes increases oxidative stress in tissues of both humans and animals, and increased oxidative stress might play a role in the development of diabetic complications (8,12,13,14). 

Phrase: "Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "oxidative stress in tissues of both humans"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   748   C0038435:Stress [Finding]
   748   C0311404:Oxidative [Functional Concept]

Phrase: "and"

Phrase: "animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "and"

Phrase: "increased oxidative stress"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   913   C0231298:Increased stress [Functional Concept]
   901   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   827   C0311404:Oxidative [Functional Concept]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "might"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in the development of diabetic complications"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "(8,"

Phrase: "12,"

Phrase: "13,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.17: Oxidative stress develops in the retina of diabetic animals and galactose-fed animals (9,13,15), indicating that oxidative stress is at least associated with the development of retinopathy. 

Phrase: "Oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "develops in the retina of diabetic animals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0003062:Animals [Animal]
   748   C0035298:Retina [Body Part, Organ, or Organ Component]
   748   C0241863:DIABETIC [Finding]
   748   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "galactose-fed animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "(9,"

Phrase: "13,"

Phrase: "15"

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "is at least"

Phrase: "associated with the development of retinopathy."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0035309:Retinopathy [Disease or Syndrome]
   753   C0243107:development [Physiologic Function]
   753   C0678723:Development [Organism Function]
   753   C1527148:Development [Functional Concept]
   753   C1962966:Retinopathy [Finding]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.18: Consistent with this, Armstrong et al. 

Phrase: "Consistent with this,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "Armstrong et al."
Processing 00000000.tx.19: (8) reported a correlation between increased serum lipid hydroperoxides and the prevalence of retinopathy in diabetic patients. 

Phrase: "(8"

Phrase: ")"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "a correlation between increased serum lipid hydroperoxides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "the prevalence of retinopathy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033105:Prevalence [Quantitative Concept]
   770   C0220900:prevalence [Quantitative Concept]

Phrase: "in diabetic patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.20: Our previous studies showed that dietary supplementation with antioxidants can inhibit diabetes-induced abnormalities of retinal metabolism (7,9,13,16), but whether antioxidants can inhibit the development of retinopathy has been studied little. 

Phrase: "Our previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that dietary supplementation with antioxidants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0242297:Dietary Supplementation [Therapeutic or Preventive Procedure]
           Supplementation

Phrase: "can"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "diabetes-induced abnormalities of retinal metabolism"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   783   C0035300:Retinal abnormalities [Finding]
   753   C0000768:Abnormalities [Congenital Abnormality]
   753   C0000769:abnormalities [Functional Concept]
   719 E C1704258:Abnormality [Finding]

Phrase: "(7,"

Phrase: "9,"

Phrase: "13,"

Phrase: "16"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "whether"

Phrase: "antioxidants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003402:Antioxidants [Pharmacologic Substance]

Phrase: "can"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the development of retinopathy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "studied little."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
   861   C0700321:Little [Quantitative Concept]
   861   C2700395:Little [Quantitative Concept]
Processing 00000000.tx.21: A retrospective study in type 2 diabetic patients, based on a single 24-h diet recall, found no evidence that antioxidant supplementation (vitamins C and E and -carotene) could decrease the severity of retinopathy (17). 

Phrase: "A retrospective study in type 2 diabetic patients,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0035363:Retrospective Study [Research Activity]
           retrospective
   767   C0035171:Study Type [Research Activity]
   767   C2985227:Study Type [Research Activity]
   744   C0557651:Study [Manufactured Object]
   744   C1514923:Retrospective [Qualitative Concept]
   744   C2603343:Study [Research Activity]

Phrase: "based on a single 24-h diet recall,"
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   744   C0012155:Diet [Food]
   744   C0033727:H+ [Element, Ion, or Isotope]
   744   C0034770:Recall [Mental Process]
   744   C0037179:Single [Population Group]
   744   C0087136:single [Finding]
   744   C0205171:Single [Quantitative Concept]
   744   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441932:H+ [Classification]
   744   C0564385:/h [Quantitative Concept]
   744   C1442959:Diet [Organism Function]
   744   C1519433:DIET [Therapeutic or Preventive Procedure]
   744   C1527178:Based [Functional Concept]
   744   C1705180:Recall [Governmental or Regulatory Activity]
   744   C1705938:Based [Idea or Concept]
   744   C2361119:Recall [Clinical Attribute]
   744   C2983588:DIET [Food]
   711 E C0002055:base [Inorganic Chemical]
   711 E C0178499:Base [Chemical Viewed Functionally]
   711 E C1880279:Base [Biomedical or Dental Material]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that antioxidant supplementation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242297:Supplementation [Therapeutic or Preventive Procedure]

Phrase: "(vitamins C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0003968:Vitamin C [Organic Chemical,Pharmacologic Substance,Vitamin]
   983   C2349136:Vitamin C [Organic Chemical,Vitamin]

Phrase: "and"

Phrase: "E"

Phrase: "and -"

Phrase: "carotene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007269:Carotene [Biologically Active Substance,Organic Chemical]

Phrase: ")"

Phrase: "could"

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the severity of retinopathy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439793:Severity [Qualitative Concept]
   770   C2983285:Severity [Intellectual Product]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.22: Hammes et al. 

Phrase: "Hammes et al."
Processing 00000000.tx.23: (18) observed that nicanartine, a drug that has cholesterol-lowering and antioxidant properties, partially inhibited pericyte loss in diabetic rats but failed to have any effect on the number of acellular capillaries or microaneurysms. 

Phrase: "(18"

Phrase: ")"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that nicanartine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0391211:nicanartine [Organic Chemical,Pharmacologic Substance]

Phrase: "a drug"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0013227:Drug [Pharmacologic Substance]
  1000   C1254351:Drug [Pharmacologic Substance]
   944 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   944 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   907 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "that"

Phrase: "has"

Phrase: "cholesterol-lowering"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0441994:lowering [Spatial Concept]
   861   C2003888:Lowering [Activity]
   827 E C1548802:Lower [Body Location or Region]

Phrase: "and"

Phrase: "antioxidant properties,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]

Phrase: "partially"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "pericyte loss in diabetic rats"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "but"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "any effect on the number of acellular capillaries"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "microaneurysms."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333101:Microaneurysms [Anatomical Abnormality,Disease or Syndrome]
Processing 00000000.tx.24: Diabetic rats that were given the water-soluble antioxidant Trolox for 5 months partially normalized a diabetes-induced change in ratio of retinal capillary endothelial cells to pericytes (19), but whether this finding was confounded by differences in severity of hyperglycemia (the initial cause of the retinal lesions) between experimental groups was not considered. 

Phrase: "Diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "that"

Phrase: "were"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the water-soluble antioxidant Trolox for 5 months partially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0147003:Trolox [Organic Chemical,Pharmacologic Substance]

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "a diabetes-induced change in ratio of retinal capillary endothelial cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0392747:Change [Functional Concept]
   738   C0443172:change [Quantitative Concept]
   738   C1705241:Change [Quantitative Concept]

Phrase: "to pericytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598800:Pericytes [Cell]

Phrase: "(19"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "whether"

Phrase: "this finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "was"

Phrase: "confounded by differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "in severity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439793:Severity [Qualitative Concept]
  1000   C2983285:Severity [Intellectual Product]
   928 E C0205082:Severe [Qualitative Concept]

Phrase: "of hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "("

Phrase: "the initial cause of the retinal lesions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0015127:cause [Functional Concept]
   748   C1524003:Cause [Conceptual Entity]

Phrase: ")"

Phrase: "between experimental groups"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1517586:Experimental [Qualitative Concept]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "considered."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]
Processing 00000000.tx.25: In the present study, we investigated the effect of long-term administration of two different mixtures of antioxidants on the development of retinal capillary lesions in two animal models of the early stages of diabetic retinopathy: alloxan-diabetic rats and galactose-fed rats. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the effect of long-term administration of two different mixtures of antioxidants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0023983:Long-Term Effect [Phenomenon or Process]
   736   C1280500:Effect [Qualitative Concept]
   736   C2348382:Effect [Qualitative Concept]
   734   C3179302:Antioxidant Effect [Physiologic Function]

Phrase: "on the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of retinal capillary"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006901:Capillary [Body Part, Organ, or Organ Component]
   861   C0935624:Capillary [Body Part, Organ, or Organ Component]
   861   C1280521:Capillary [Body Part, Organ, or Organ Component]

Phrase: "lesions in two animal models of the early stages of diabetic retinopathy"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   753   C0011884:Diabetic Retinopathy [Disease or Syndrome]
   753   C0599779:Models, Animal [Animal]
   753   C2363430:early stages [Temporal Concept]
   736   C0003062:Animal [Animal]
   736   C0035309:Retinopathy [Disease or Syndrome]
   736   C0205448:Two [Quantitative Concept]
   736   C0221198:Lesion [Finding]
   736   C0241863:DIABETIC [Finding]
   736   C1279919:Early [Temporal Concept]
   736   C1306673:Stages [Qualitative Concept]
   736 E C1517886:Early Stage [Classification]
   736   C1546698:Lesion [Intellectual Product]
   736   C1962966:Retinopathy [Finding]
   736   C3161035:Models [Intellectual Product]
   703 E C0205390:Stage [Temporal Concept]
   703 E C1300072:Stage [Clinical Attribute]

Phrase: ":"

Phrase: "alloxan-diabetic rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "and"

Phrase: "galactose-fed rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
Processing 00000000.tx.26: To help interpret the effects of the dietary supplements on development of retinal histopathology, we investigated whether hyperglycemia-induced abnormalities of retinal metabolism (oxidative stress, activation of protein kinase C [PKC], and nitric oxides [NO]) persisted for the entire duration when the retinopathy was developing and could be inhibited by antioxidants over this duration.  

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "interpret"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285553:interpret [Functional Concept]

Phrase: "the effects of the dietary supplements"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "on development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of retinal histopathology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243140:histopathology [Functional Concept]
   861   C0677043:Histopathology [Biomedical Occupation or Discipline]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "whether"

Phrase: "hyperglycemia-induced abnormalities of retinal metabolism"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   783   C0035300:Retinal abnormalities [Finding]
   753   C0000768:Abnormalities [Congenital Abnormality]
   753   C0000769:abnormalities [Functional Concept]
   719 E C1704258:Abnormality [Finding]

Phrase: "(oxidative stress,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "activation of protein kinase C [PKC],"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   900   C3546691:protein kinase C activation [Molecular Function]
   844   C1819041:protein kinase activation [Cell Function]
   797   C0599177:protein activation [Genetic Function]
   760   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "nitric oxides [NO]"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0028128:nitric oxides [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:Oxides [Inorganic Chemical]
   827 E C2986642:oxide [Chemical Viewed Functionally]

Phrase: ")"

Phrase: "persisted for the entire duration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439751:Entire [Quantitative Concept]
   760   C0444667:Entire [Quantitative Concept]
   760   C0449238:Duration [Temporal Concept]
   760   C2926735:Duration [Pharmacologic Substance]

Phrase: "when"

Phrase: "the retinopathy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035309:Retinopathy [Disease or Syndrome]
  1000   C1962966:Retinopathy [Finding]

Phrase: "was"

Phrase: "developing"

Phrase: "and"

Phrase: "could"

Phrase: "be"

Phrase: "inhibited by antioxidants"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0003402:Antioxidants [Pharmacologic Substance]
   790   C0311403:Inhibited [Qualitative Concept]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "over this duration."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449238:Duration [Temporal Concept]
  1000   C2926735:Duration [Pharmacologic Substance]
Processing 00000000.tx.27: RESEARCH DESIGN AND METHODS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Male Sprague-Dawley rats that weighed 200 g were assigned randomly to be made diabetic, to be made experimentally galactosemic, or to remain as normal controls. 

Phrase: "RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035171:Research Design [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   876   C0086912:methods research [Research Activity]
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Male Sprague-Dawley rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0034715:Rats, Sprague-Dawley [Mammal]
   861   C2699239:Sprague-Dawley [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "that"

Phrase: "weighed"

Phrase: "200 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "assigned"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516050:Assigned [Functional Concept]
  1000   C1552601:assigned [Intellectual Product]

Phrase: "randomly to"

Phrase: "be"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "diabetic, to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0241863:DIABETIC [Finding]

Phrase: "be"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "experimentally galactosemic,"

Phrase: "or"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "remain as normal controls."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   799   C2705716:normal control [Qualitative Concept]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C2347086:% Normal [Quantitative Concept]
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.28: Diabetes was induced by an injection of alloxan monohydrate (45 mg/kg i.v.) after a 24-h fast, and insulin was given as needed (02 units of NPH insulin subcutaneously, two to five times per week) to achieve slow weight gain without preventing hyperglycemia and glucosuria. 

Phrase: "Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "was"

Phrase: "induced by an injection of alloxan monohydrate"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0002151:Alloxan [Biologically Active Substance,Organic Chemical]
   748   C0021485:injection [Therapeutic or Preventive Procedure]
   748   C0205263:Induced [Functional Concept]
   748   C1272883:Injection [Biomedical or Dental Material]
   748   C1533685:Injection [Therapeutic or Preventive Procedure]
   748   C1572759:MONOHYDRATE [Organic Chemical]
   748   C1828121:Injection [Functional Concept]

Phrase: "(45 mg/kg"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0439272:mg kg [Quantitative Concept]
   827   C0022718:KG [Geographic Area]
   827   C0439209:kg [Quantitative Concept]
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "i.v."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: "after a 24-h fast,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "given as needed"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0558288:given as needed [Temporal Concept]
   790   C0027552:Needed [Qualitative Concept]
   790   C0686904:needed [Functional Concept]
   790   C1442162:GIVEN [Conceptual Entity]
   790   C1550718:given [Idea or Concept]
   790   C3244317:given [Intellectual Product]
   756 E C1947971:Give [Functional Concept]

Phrase: "(02 units of NPH insulin subcutaneously,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0439148:Units [Quantitative Concept]
   753   C1519795:Units [Quantitative Concept]
   719 E C1704753:Unit [Manufactured Object]
   719 E C1880519:Unit [Quantitative Concept]

Phrase: "two to five times per week"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   783   C0456698:times/week [Quantitative Concept]
   783   C1948050:Two Times [Quantitative Concept]
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "achieve"

Phrase: "slow weight gain without preventing hyperglycemia"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C1856937:Slow weight gain [Finding]
   790   C0043094:Weight Gain [Finding]
   790   C2911647:Weight gain [Finding]
   753   C0005910:weight [Organism Attribute]
   753   C0043100:Weight [Quantitative Concept]
   753   C1305866:weight [Diagnostic Procedure]
   753   C1517378:Gain [Quantitative Concept]
   753   C1705104:Weight [Idea or Concept]
   748 E C0231246:weight gaining [Sign or Symptom]

Phrase: "and"

Phrase: "glucosuria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017979:Glucosuria [Finding]
Processing 00000000.tx.29: Thus, diabetic rats were insulin-deficient but not grossly catabolic. 

Phrase: "Thus,"

Phrase: "diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "were"

Phrase: "insulin-deficient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011155:Deficient [Functional Concept]
   861   C1636779:% deficient [Quantitative Concept]

Phrase: "but"

Phrase: "not grossly catabolic."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0311402:catabolic [Functional Concept]
   827   C1516314:Catabolic [Physiologic Function]
Processing 00000000.tx.30: Experimental galactosemia was induced in normal rats by feeding a diet of 30% D-galactose (wt/wt in diet). 

Phrase: "Experimental galactosemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016952:Galactosaemia [Disease or Syndrome]
   861   C0268151:GALACTOSEMIA [Disease or Syndrome]

Phrase: "was"

Phrase: "induced in normal rats"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C0205263:Induced [Functional Concept]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C2347086:% Normal [Quantitative Concept]

Phrase: "by feeding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0204695:Feeding [Health Care Activity]
  1000   C2987508:Feeding [Activity]

Phrase: "a diet of 30%"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0012155:Diet [Food]
   770   C1442959:Diet [Organism Function]
   770   C1519433:DIET [Therapeutic or Preventive Procedure]
   770   C2983588:DIET [Food]

Phrase: "D-"

Phrase: "galactose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016945:Galactose [Biologically Active Substance,Carbohydrate]

Phrase: "(wt/wt in diet"

Phrase: ")."
Processing 00000000.tx.31: Representative diabetic rats and galactose-fed rats received diets that were supplemented with one of two antioxidant mixtures. 

Phrase: "Representative diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "galactose-fed rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "diets"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0012155:Diets [Food]
   966 E C1442959:Diet [Organism Function]
   966 E C1519433:DIET [Therapeutic or Preventive Procedure]
   966 E C2983588:DIET [Food]
   916 E C2699635:DIETARY [Functional Concept]

Phrase: "that"

Phrase: "were"

Phrase: "supplemented with one of two antioxidant mixtures."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0003402:Antioxidant [Pharmacologic Substance]
   748   C0205447:One [Quantitative Concept]
   748   C0205448:Two [Quantitative Concept]
   748   C0439962:mixtures [Substance]
   714   C0242295:Supplement [Food]
   714   C1947943:Supplement [Intellectual Product]
   714   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.32: In the first experiment, the "vitamins C+E diet," both diabetic rats and galactosemic rats were fed ascorbic acid and -dl-tocopherol (10 and 1 g/kg diet, respectively). 

Phrase: "In the first experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "the ""vitamins C+E diet,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0012155:Diet [Food]
   812   C1442959:Diet [Organism Function]
   812   C1519433:DIET [Therapeutic or Preventive Procedure]
   812   C2983588:DIET [Food]
   741 E C2699635:DIETARY [Functional Concept]

Phrase: """"

Phrase: "both diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "galactosemic rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "ascorbic acid"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0003968:Ascorbic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   944 E C0699147:Cecon [Carbohydrate,Pharmacologic Substance,Vitamin]
   944 E C0699151:Cenolate [Carbohydrate,Pharmacologic Substance,Vitamin]
   944 E C0699153:Cevalin [Carbohydrate,Pharmacologic Substance,Vitamin]
   916 E C2349136:Vitamin C [Organic Chemical,Vitamin]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and -"

Phrase: "dl-tocopherol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0087096:Tocopherol [Lipid,Pharmacologic Substance,Vitamin]
   861   C3255108:Tocopherol [Pharmacologic Substance]

Phrase: "(10"

Phrase: "and"

Phrase: "1 g/kg diet,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0012155:Diet [Food]
   812   C1442959:Diet [Organism Function]
   812   C1519433:DIET [Therapeutic or Preventive Procedure]
   812   C2983588:DIET [Food]
   741 E C2699635:DIETARY [Functional Concept]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.33: In the other antioxidant diet, the "multi-antioxidant diet," diabetic rats and galactosemic rats received a diet that was supplemented with multiple antioxidants consisting of ascorbic acid (1 g/kg), Trolox (500 mg/kg), dl--tocopherol acetate (250 mg/kg), N-acetyl cysteine (200 mg/kg), -carotene (45 mg/kg), and selenium (0.1 mg/kg). 

Phrase: "In the"

Phrase: "other antioxidant diet,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0012155:Diet [Food]
   861   C1442959:Diet [Organism Function]
   861   C1519433:DIET [Therapeutic or Preventive Procedure]
   861   C2983588:DIET [Food]
   789 E C2699635:DIETARY [Functional Concept]

Phrase: "the ""multi-antioxidant diet,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0012155:Diet [Food]
   827   C1442959:Diet [Organism Function]
   827   C1519433:DIET [Therapeutic or Preventive Procedure]
   827   C2983588:DIET [Food]
   755 E C2699635:DIETARY [Functional Concept]

Phrase: """ diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "galactosemic rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "a diet"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0012155:Diet [Food]
  1000   C1442959:Diet [Organism Function]
  1000   C1519433:DIET [Therapeutic or Preventive Procedure]
  1000   C2983588:DIET [Food]
   928 E C2699635:DIETARY [Functional Concept]

Phrase: "that"

Phrase: "was"

Phrase: "supplemented with multiple antioxidants"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0003402:Antioxidants [Pharmacologic Substance]
   770   C0439064:Multiple [Quantitative Concept]
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]

Phrase: "consisting of ascorbic acid"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   833   C0003968:Ascorbic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   777 E C0699147:Cecon [Carbohydrate,Pharmacologic Substance,Vitamin]
   777 E C0699151:Cenolate [Carbohydrate,Pharmacologic Substance,Vitamin]
   777 E C0699153:Cevalin [Carbohydrate,Pharmacologic Substance,Vitamin]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   750 E C2349136:Vitamin C [Organic Chemical,Vitamin]
   737   C0332529:CONSIST [Qualitative Concept]

Phrase: "(1 g/kg"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1300563:g/kg [Quantitative Concept]
   827   C0022718:KG [Geographic Area]
   827   C0439209:kg [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Trolox"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0147003:Trolox [Organic Chemical,Pharmacologic Substance]

Phrase: "(500 mg/kg"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0439272:mg kg [Quantitative Concept]
   827   C0022718:KG [Geographic Area]
   827   C0439209:kg [Quantitative Concept]
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "dl--tocopherol acetate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0078373:Tocopherol Acetate [Organic Chemical,Pharmacologic Substance,Vitamin]
   901   C1999896:Tocopherol Acetate [Organic Chemical,Pharmacologic Substance,Vitamin]
   827   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]

Phrase: "(250 mg/kg"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0439272:mg kg [Quantitative Concept]
   827   C0022718:KG [Geographic Area]
   827   C0439209:kg [Quantitative Concept]
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "N-acetyl cysteine"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0001047:N-Acetyl Cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   845 E C0699252:Mucomyst [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(200 mg/kg"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0439272:mg kg [Quantitative Concept]
   827   C0022718:KG [Geographic Area]
   827   C0439209:kg [Quantitative Concept]
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")"

Phrase: ", -"

Phrase: "carotene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007269:Carotene [Biologically Active Substance,Organic Chemical]

Phrase: "(45 mg/kg"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0439272:mg kg [Quantitative Concept]
   827   C0022718:KG [Geographic Area]
   827   C0439209:kg [Quantitative Concept]
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "selenium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036581:Selenium [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
  1000   C2348282:Selenium [Element, Ion, or Isotope]

Phrase: "(0.1 mg/kg"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0439272:mg kg [Quantitative Concept]
   812   C0022718:KG [Geographic Area]
   812   C0439209:kg [Quantitative Concept]
   812   C0439269:mg% [Quantitative Concept]
   812   C1960952:mg % [Quantitative Concept]
   812   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.34: The antioxidants were mixed into the powdered diet, antioxidant diets were replaced weekly, and food consumption was measured to calculate the amount of antioxidants consumed. 

Phrase: "The antioxidants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003402:Antioxidants [Pharmacologic Substance]

Phrase: "were"

Phrase: "mixed into the powdered diet,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0012155:Diet [Food]
   760   C0205430:Mixed [Functional Concept]
   760   C1442959:Diet [Organism Function]
   760   C1519433:DIET [Therapeutic or Preventive Procedure]
   760   C2983588:DIET [Food]
   760   C3160715:Mixed [Finding]
   726 E C1421951:MIX [Gene or Genome]
   726 E C1720722:Mix [Qualitative Concept]

Phrase: "antioxidant diets"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0012155:Diets [Food]
   827 E C1442959:Diet [Organism Function]
   827 E C1519433:DIET [Therapeutic or Preventive Procedure]
   827 E C2983588:DIET [Food]
   777 E C2699635:DIETARY [Functional Concept]

Phrase: "were"

Phrase: "replaced"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0559956:Replaced [Functional Concept]
  1000   C1299987:replaced [Functional Concept]
   966 E C1554078:Replace [Idea or Concept]

Phrase: "weekly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332174:Weekly [Temporal Concept]

Phrase: "and"

Phrase: "food consumption"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2983605:Food Consumption [Activity]
   861   C0009830:Consumption [Activity]
   861   C1947907:Consumption [Physiologic Function]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "calculate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441506:Calculate [Activity]

Phrase: "the amount of antioxidants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "consumed."
Processing 00000000.tx.35: GHb (an estimate of the average level of hyperglycemia over the previous 23 months) was measured at least three to four times per year in each animal by affinity chromatography (Glyc-Affin; Pierce, Rockford, IL). 

Phrase: "GHb ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000503:GHB [Organic Chemical,Pharmacologic Substance]

Phrase: "an estimate of the average level of hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0750572:Estimate [Quantitative Concept]

Phrase: "over the previous 23 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439231:months [Temporal Concept]
   793 E C0439507:/month [Temporal Concept]

Phrase: ")"

Phrase: "was"

Phrase: "measured at least three"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0205449:Three [Quantitative Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "to four times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "per year"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439234:year [Temporal Concept]
  1000   C0439508:/year [Temporal Concept]

Phrase: "in each animal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animal [Animal]

Phrase: "by affinity chromatography"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0008551:Chromatography, Affinity [Laboratory Procedure]
   861   C0008550:Chromatography [Laboratory Procedure]
   861   C1510827:Affinity [Natural Phenomenon or Process]
   761 E C0302647:chromatograph [Medical Device]

Phrase: "(Glyc-Affin"

Phrase: "; Pierce,"

Phrase: "Rockford,"

Phrase: "IL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: ")."
Processing 00000000.tx.36: Urine volume (24-h duration) was measured over 23 consecutive days every 34 months. 

Phrase: "Urine volume"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0232856:Urine volume [Clinical Attribute]
  1000   C1278293:Urine volume [Laboratory Procedure]
  1000   C1287298:Urine volume [Finding]
   861   C0042036:Urine [Body Substance]
   861   C0042037:urine [Functional Concept]
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]
   861   C2963137:Urine [Body Substance]

Phrase: "(24-h duration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449238:Duration [Temporal Concept]
   827   C2926735:Duration [Pharmacologic Substance]

Phrase: ")"

Phrase: "was"

Phrase: "measured over 23 consecutive days"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   760   C0439228:days [Temporal Concept]
   760   C0444706:Measured [Qualitative Concept]
   760   C0450348:23 [Quantitative Concept]
   760   C1707491:Consecutive [Qualitative Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
   726 E C0332173:/day [Temporal Concept]
   726 E C0439505:/day [Temporal Concept]

Phrase: "every 34 months."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439231:months [Temporal Concept]
   827 E C0439507:/month [Temporal Concept]
Processing 00000000.tx.37: Body weight and average daily food consumption were measured weekly. 

Phrase: "Body weight"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0005910:Body Weight [Organism Attribute]
           weight
  1000   C1305866:body weight [Diagnostic Procedure]
           weight
   861   C0043100:Weight [Quantitative Concept]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   861   C1705104:Weight [Idea or Concept]
   777 E C1995017:Bodies [Cell Component]

Phrase: "and"

Phrase: "average daily food consumption"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C2983605:Food Consumption [Activity]
   812   C0009830:Consumption [Activity]
   812   C1947907:Consumption [Physiologic Function]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "weekly."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332174:Weekly [Temporal Concept]
Processing 00000000.tx.38: These experiments conformed to the ARVO Resolution on the Use of Animals in Research. 

Phrase: "These experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "conformed to the ARVO Resolution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1514893:Resolution [Idea or Concept]
   760   C1706463:Resolution [Quantitative Concept]
   760   C2699488:Resolution [Conceptual Entity]

Phrase: "on the Use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "of Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "in Research."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]
Processing 00000000.tx.39: The rats that received the vitamins C+E diet were killed after 18 months of vitamins C+E supplementation, and the rats that received the multi-antioxidant diet were killed 1214 months after initiation of the multi-antioxidant diet. 

Phrase: "The rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "that"

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "the vitamins C+E diet"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0012155:Diet [Food]
   812   C1442959:Diet [Organism Function]
   812   C1519433:DIET [Therapeutic or Preventive Procedure]
   812   C2983588:DIET [Food]
   741 E C2699635:DIETARY [Functional Concept]

Phrase: "were"

Phrase: "killed after 18 months of vitamins C+E supplementation,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   762   C0302837:supplementation vitamins [Pharmacologic Substance]
   748   C0003968:Vitamin C [Organic Chemical,Pharmacologic Substance,Vitamin]
   748   C2349136:Vitamin C [Organic Chemical,Vitamin]
   745   C0042874:Vitamin E [Lipid,Pharmacologic Substance,Vitamin]
   742   C0042890:Vitamins [Organic Chemical,Pharmacologic Substance,Vitamin]
   742   C0162388:killed [Social Behavior]
   742   C0242297:Supplementation [Therapeutic or Preventive Procedure]
   742   C0439231:months [Temporal Concept]
   708 E C0439507:/month [Temporal Concept]
   708 E C0681205:Kill [Idea or Concept]
   708 E C1550555:kill [Functional Concept]

Phrase: "and"

Phrase: "the rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "that"

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "the multi-antioxidant diet"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0012155:Diet [Food]
   827   C1442959:Diet [Organism Function]
   827   C1519433:DIET [Therapeutic or Preventive Procedure]
   827   C2983588:DIET [Food]
   755 E C2699635:DIETARY [Functional Concept]

Phrase: "were"

Phrase: "killed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:killed [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: "1214 months after initiation of the multi-antioxidant diet."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0439231:months [Temporal Concept]
   708 E C0439507:/month [Temporal Concept]
Processing 00000000.tx.40: Appropriate normal, diabetic, and galactose-fed controls were killed simultaneously. 

Phrase: "Appropriate normal, diabetic,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "galactose-fed controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0243148:control [Qualitative Concept]
   793   C1550141:Control [Substance]
   793   C1882979:Control [Conceptual Entity]
   793   C2587213:Control [Functional Concept]
   793   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "killed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:killed [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: "simultaneously."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521115:simultaneously [Temporal Concept]
Processing 00000000.tx.41: One eye from each animal was placed in buffered formalin for isolation of the retinal vasculature by the trypsin digest technique (described below). 

Phrase: "One eye from each animal"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0015392:Eye [Body Part, Organ, or Organ Component]
   760   C1280202:Eye [Body Part, Organ, or Organ Component]
   704 E C0029144:optic [Occupation or Discipline]
   704 E C0042789:Ocular [Organism Function]
   704 E C1299003:Ocular [Spatial Concept]

Phrase: "was"

Phrase: "placed in buffered formalin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0949307:Formalin [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   737   C0442504:Place [Spatial Concept]
   737   C1704765:Place [Functional Concept]
   737   C1882509:Place [Activity]
   737   C3496241:place [Disease or Syndrome]

Phrase: "for isolation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0204727:Isolation [Therapeutic or Preventive Procedure]
  1000   C0205409:Isolation [Functional Concept]
  1000   C0220862:isolation [Laboratory Procedure]
   928 E C1548221:Isolated [Idea or Concept]

Phrase: "of the retinal vasculature"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005839:vasculature [Body Part, Organ, or Organ Component]

Phrase: "by the trypsin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "digest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0868946:digest [Physiologic Function]

Phrase: "technique"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449851:Technique [Functional Concept]
   916 E C0025664:techniques [Intellectual Product]

Phrase: "("

Phrase: "described below"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.42: From the other eye, the fresh retina was collected gently using a microspatula and frozen for biochemical analysis. 

Phrase: "From the"

Phrase: "other eye,"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0015392:Eye [Body Part, Organ, or Organ Component]
  1000   C1280202:Eye [Body Part, Organ, or Organ Component]
   944 E C0029144:optic [Occupation or Discipline]
   944 E C0042789:Ocular [Organism Function]
   944 E C1299003:Ocular [Spatial Concept]
   907 E C0014236:Ophthalmia [Disease or Syndrome]
   907 E C0700042:Oculus [Body Location or Region]

Phrase: "the fresh retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035298:Retina [Body Part, Organ, or Organ Component]
   861   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "gently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1638411:Gently [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a microspatula"

Phrase: "and"

Phrase: "frozen for biochemical analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0016701:Frozen [Natural Phenomenon or Process]
   770   C0205474:Biochemical [Functional Concept]
   770   C0677542:Frozen [Functional Concept]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
Processing 00000000.tx.43: A small wedge of retina was collected for measurement of capillary basement membrane thickness from representative animals only in the vitamins C+E experiment. 

Phrase: "A small wedge of retina"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439639:Wedge [Spatial Concept]

Phrase: "was"

Phrase: "collected for measurement of capillary basement membrane thickness"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0004799:Basement membrane [Tissue]
   744   C0006901:Capillary [Body Part, Organ, or Organ Component]
   744   C0025255:Membrane [Tissue]
   744   C0242485:Measurement [Functional Concept]
   744   C0596901:Membrane [Cell Component]
   744   C0935624:Capillary [Body Part, Organ, or Organ Component]
   744   C1280412:Thickness [Qualitative Concept]
   744   C1280521:Capillary [Body Part, Organ, or Organ Component]
   744   C1516695:Collected [Idea or Concept]
   744   C1516698:Collected [Functional Concept]
   744   C1706182:Membrane [Manufactured Object]
   744   C1979853:Basement [Cell Component]

Phrase: "from representative animals only"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "in the vitamins C+E experiment."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0681814:Experiment [Research Activity]
   812   C1706386:Experiment [Conceptual Entity]
   741 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.44: Metabolic abnormalities in the retina. 

Phrase: "Metabolic abnormalities in the retina."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   781   C0035300:RETINA ABNORMALITY [Finding]
   760   C0000768:Abnormalities [Congenital Abnormality]
   760   C0000769:abnormalities [Functional Concept]
   726 E C1704258:Abnormality [Finding]
Processing 00000000.tx.45: For estimation of lipid peroxide, levels of thiobarbituric acid substances (TBARS) were quantified in the retina by measuring the absorbance of malonaldehyde-thiobarbituric acid adducts formed by acid hydrolysis at 100C at 535 nm (20). 

Phrase: "For estimation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0680844:estimation [Mental Process]
  1000   C0681916:Estimation [Quantitative Concept]
  1000   C0750572:Estimation [Quantitative Concept]

Phrase: "of lipid peroxide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023776:lipid peroxide [Lipid]
   861   C0023779:Lipid [Lipid]
   861   C0031180:Peroxide [Inorganic Chemical]

Phrase: "levels of thiobarbituric acid substances (TBARS)"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "quantified in the retina"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0035298:Retina [Body Part, Organ, or Organ Component]
   770   C1278894:Retina [Body Part, Organ, or Organ Component]
   737   C1709793:Quantify [Quantitative Concept]

Phrase: "by measuring"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:measuring [Qualitative Concept]
  1000   C0449770:measuring [Quantitative Concept]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the absorbance of malonaldehyde-thiobarbituric acid adducts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1268822:Absorbance [Clinical Attribute]
   748   C2825050:Absorbance [Phenomenon or Process]

Phrase: "formed by acid hydrolysis"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0001128:Acid [Chemical]
   770   C0020291:Hydrolysis [Natural Phenomenon or Process]
   770   C0202406:Acid [Laboratory Procedure]
   770   C0205431:Formed [Functional Concept]
   737 E C0348078:Form [Qualitative Concept]
   737 E C0376315:Form [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "at 100C"

Phrase: "at 535 nm (20"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: ")."
Processing 00000000.tx.46: A standard of 1,1,3,3-tetramethoxy propane, which is sensitive up to 0.3 mol/l, was used. 

Phrase: "A standard of 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1442989:Standard [Qualitative Concept]
   770   C2828392:Standard [Intellectual Product]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "3-tetramethoxy propane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033434:Propane [Organic Chemical]

Phrase: "which"

Phrase: "is"

Phrase: "sensitive up to 0.3 mol/l,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0332324:Sensitive to [Functional Concept]
           Sensitive
   748   C1550474:sensitive [Idea or Concept]

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.47: TBARS in retina are expressed relative to the protein concentration. 

Phrase: "TBARS in retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0001128:acid substances [Chemical]
   760   C0439861:Substances [Substance]

Phrase: "are"

Phrase: "expressed"

Phrase: "relative to the protein concentration."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.48: Total PKC activity was measured in fresh retina (<0.5 retina/tube) using an in situ assay (7,21). 

Phrase: "Total PKC activity"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   937   C1150572:protein kinase C activity [Molecular Function]
   888   C1150527:protein kinase activity [Molecular Function]
   888   C3642159:Protein C Activity [Laboratory Procedure]
   875   C1537044:protein activity [Molecular Function]
   870 E C2261495:protein phosphokinase activity [Molecular Function]
   853   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   717   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "measured in fresh retina"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0035298:Retina [Body Part, Organ, or Organ Component]
   770   C0443224:Fresh [Qualitative Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C1278894:Retina [Body Part, Organ, or Organ Component]
   770   C2827486:Fresh [Body Substance]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "("

Phrase: "<0.5 retina/tube"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0175730:Tube [Medical Device]
   812   C1547937:Tube NOS [Intellectual Product]
   812   C1561954:tube [Conceptual Entity]
   812   C1704730:TUBE [Medical Device]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an in situ assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
   734   C0444498:In situ [Spatial Concept]

Phrase: "(7,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.49: PKC activity was calculated on the basis of the transfer of 32P from [-32P]ATP to the octapeptide (RKRTLRRL), corresponding to the threonine phosphorylation site of the epidermal growth factor receptor residue 691698. 

Phrase: "PKC activity"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
  1000   C1150572:protein kinase C activity [Molecular Function]
   923   C1150527:protein kinase activity [Molecular Function]
   923   C3642159:Protein C Activity [Laboratory Procedure]
   905 E C2261495:protein phosphokinase activity [Molecular Function]
   902   C1537044:protein activity [Molecular Function]
   875   C1150423:kinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   708   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   708   C1168438:Protein C [Laboratory Procedure]
   708   C1418943:PROTEIN C [Gene or Genome]
   708   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "calculated on the basis of the transfer of 32P"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0040671:Transfer [Mental Process]
   742   C0444686:Calculated [Functional Concept]
   742   C1441506:Calculated [Activity]
   742   C1443182:Calculated [Laboratory Procedure]
   742   C1527178:Basis [Functional Concept]
   742   C1553631:32p [Medical Device]
   742   C1705822:Transfer [Activity]
   742   C1874451:Basis [Pharmacologic Substance]

Phrase: "from"

Phrase: "[-32P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553631:32p [Medical Device]

Phrase: "]ATP to the octapeptide"

Phrase: "(RKRTLRRL"

Phrase: ")"

Phrase: ","

Phrase: "corresponding to the threonine phosphorylation site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C1515418:Threonine Phosphorylation Site [Amino Acid Sequence]
   790   C1519063:Phosphorylation Site [Amino Acid Sequence]
   753   C0031715:Phosphorylation [Molecular Function]
   753   C0040005:Threonine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0205145:Site [Spatial Concept]
   753   C1158886:Phosphorylation [Molecular Function]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]

Phrase: "of the epidermal growth factor receptor residue 691698."
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   901   C0034802:Epidermal Growth Factor Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   901   C1414313:EPIDERMAL GROWTH FACTOR RECEPTOR [Gene or Genome]
   861   C0206454:Growth Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1323367:epidermal growth factor [Molecular Function]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0014520:Epidermal [Tissue]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0220844:growth [Physiologic Function]
   799   C0221920:Epidermal [Spatial Concept]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C1521761:Factor [Functional Concept]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C1709915:Residue [Conceptual Entity]
   799   C1882936:RESIDUE [Phenomenon or Process]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]
   727 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.50: PKC activity was validated by measuring the enzyme in the presence of phorbol esters (100 nmol/l tetradecanoylphorbol acetate) and staurosporine (50 nmol/l). 

Phrase: "PKC activity"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
  1000   C1150572:protein kinase C activity [Molecular Function]
   923   C1150527:protein kinase activity [Molecular Function]
   923   C3642159:Protein C Activity [Laboratory Procedure]
   905 E C2261495:protein phosphokinase activity [Molecular Function]
   902   C1537044:protein activity [Molecular Function]
   875   C1150423:kinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   708   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   708   C1168438:Protein C [Laboratory Procedure]
   708   C1418943:PROTEIN C [Gene or Genome]
   708   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "validated by measuring"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0444706:measuring [Qualitative Concept]
   790   C0449770:measuring [Quantitative Concept]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "the enzyme in the presence of phorbol esters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0014442:Enzyme [Enzyme,Organic Chemical]

Phrase: "(100 nmol/l tetradecanoylphorbol acetate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0039654:Tetradecanoylphorbol Acetate [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   804   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "staurosporine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0075193:Staurosporine [Organic Chemical,Pharmacologic Substance]

Phrase: "(50 nmol/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439191:NMOLE [Quantitative Concept]

Phrase: "l)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.51: NO were determined in retina by measuring the stable metabolites of NO (nitrate+nitrite) using a fluorometric assay kit (Cayman Chemical Company, Ann Arbor, MI). 

Phrase: "NO"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0028128:nitric oxides [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:Oxides [Inorganic Chemical]
   827 E C2986642:oxide [Chemical Viewed Functionally]

Phrase: "were"

Phrase: "determined in retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035298:Retina [Body Part, Organ, or Organ Component]
   790   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "by measuring"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:measuring [Qualitative Concept]
  1000   C0449770:measuring [Quantitative Concept]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the stable metabolites of NO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0870883:Metabolites [Biologically Active Substance]
   753   C2698672:METABOLITES [Regulation or Law]

Phrase: "(nitrate+nitrite"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0883264:Nitrate+Nitrite [Inorganic Chemical,Pharmacologic Substance]
   861   C0028137:Nitrite [Chemical Viewed Structurally]
   861   C1384115:Nitrite [Inorganic Chemical]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a fluorometric assay kit (Cayman Chemical Company,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0683757:Company [Manufactured Object,Organization]

Phrase: "Ann Arbor,"

Phrase: "MI)."
Processing 00000000.tx.52: Retinal homogenate was passed through a 10-kDa filter to remove interfering substances in the sample. 

Phrase: "Retinal homogenate"

Phrase: "was"

Phrase: "passed through a 10-kDa"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1532717:kDa [Quantitative Concept]
   760   C2828386:Passed [Finding]

Phrase: "filter"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0180860:Filter [Manufactured Object]
  1000   C0581406:Filter [Medical Device]
  1000   C1522664:Filter [Intellectual Product]
  1000   C1704449:Filter [Conceptual Entity]
  1000   C1704684:Filter [Medical Device]
  1000   C1875155:FILTER [Medical Device]
   944 E C0080194:Strain [Injury or Poisoning]
   944 E C0442694:Straining [Physiologic Function]
   944 E C0456178:strain [Intellectual Product]
   944 E C1518614:Strain [Organism]
   944 E C2987481:Strain [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "interfering substances in the sample."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439861:Substances [Substance]
Processing 00000000.tx.53: For complete conversion of nitrate to nitrite, the samples were incubated with nitrate reductase for 2 h. 

Phrase: "For complete conversion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439836:Conversion [Functional Concept]

Phrase: "of nitrate"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0028125:Nitrate [Chemical Viewed Structurally]
  1000   C0699857:Nitrate [Inorganic Chemical]
   900 E C1328815:nitration [Phenomenon or Process]

Phrase: "to nitrite,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028137:Nitrite [Chemical Viewed Structurally]
  1000   C1384115:Nitrite [Inorganic Chemical]

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "incubated with nitrate reductase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0028123:nitrate reductase [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0068800:nitrate reductase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0028125:Nitrate [Chemical Viewed Structurally]
   770   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0699857:Nitrate [Inorganic Chemical]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 2 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.54: Fluorescence generated by nitrite reaction with 2,3-diaminonaphthalene was measured at excitation and emission wavelengths of 365 and 450 nm, respectively (22). 

Phrase: "Fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "generated by nitrite reaction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0028137:Nitrite [Chemical Viewed Structurally]
   770   C0443286:Reaction [Functional Concept]
   770   C1114821:Reaction [Clinical Attribute]
   770   C1384115:Nitrite [Inorganic Chemical]
   770   C3146294:Generated [Activity]

Phrase: "with 2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3-diaminonaphthalene"

Phrase: "was"

Phrase: "measured at excitation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0444706:Measured [Qualitative Concept]
   790   C0549255:Excitation [Activity]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "emission wavelengths of 365"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449819:wavelengths [Quantitative Concept]

Phrase: "and"

Phrase: "450 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "respectively"

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.55: In each experiment, the retinal tissues obtained from rats in each of the five groups (normal, diabetic, diabetes + antioxidants, galactose, and galactose + antioxidants) were run simultaneously. 

Phrase: "In each experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "the retinal tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "obtained from rats"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0034693:rats [Mammal]
   790   C0034721:Rats [Mammal]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "in each"

Phrase: "of the five groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "(normal, diabetic, diabetes + antioxidants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003402:Antioxidants [Pharmacologic Substance]

Phrase: "galactose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016945:Galactose [Biologically Active Substance,Carbohydrate]

Phrase: "and"

Phrase: "galactose + antioxidants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003402:Antioxidants [Pharmacologic Substance]

Phrase: ")"

Phrase: "were"

Phrase: "run"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035953:run [Daily or Recreational Activity]
  1000   C0600140:run [Finding]
  1000   C1704688:Run [Functional Concept]
  1000   C2346414:Run [Finding]

Phrase: "simultaneously."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521115:simultaneously [Temporal Concept]
Processing 00000000.tx.56: Tissue protein was measured by the Bradford method (23) using bovine serum albumin as standard. 

Phrase: "Tissue protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "measured by the Bradford method"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0025663:Method [Intellectual Product]
   760   C0444706:Measured [Qualitative Concept]
   760   C0449851:Method [Functional Concept]
   760   C0871511:METHOD [Intellectual Product]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "bovine serum albumin as standard."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   862   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   806   C0728877:serum albumin [Laboratory or Test Result]
   797 E C0523465:Albumin - serum [Laboratory Procedure]
   760   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0007452:Bovine [Mammal]
   760   C0229671:Serum [Body Substance]
   760   C1140701:bovine [Mammal]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
Processing 00000000.tx.57: Evaluation of retinal histopathology. 

Phrase: "Evaluation of retinal histopathology."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0220825:Evaluation [Functional Concept]
   770   C1261322:Evaluation [Health Care Activity]
Processing 00000000.tx.58: Histopathology was detected in retinal vasculature isolated by the trypsin digest technique as used previously by us (24,25). 

Phrase: "Histopathology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243140:histopathology [Functional Concept]
  1000   C0677043:Histopathology [Biomedical Occupation or Discipline]

Phrase: "was"

Phrase: "detected in retinal vasculature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0005839:vasculature [Body Part, Organ, or Organ Component]
   770   C0035298:Retinal [Body Part, Organ, or Organ Component]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "isolated by the trypsin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "digest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0868946:digest [Physiologic Function]

Phrase: "technique"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449851:Technique [Functional Concept]
   916 E C0025664:techniques [Intellectual Product]

Phrase: "as"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "previously by us (24,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.59: The trypsinized retinal vessels were stained with periodic acid-Schiff and hematoxylin for histologic evaluation. 

Phrase: "The trypsinized retinal vessels"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0035330:Retinal Vessels [Body Part, Organ, or Organ Component]
   827   C0005847:Vessels [Body Part, Organ, or Organ Component]
   793 E C1511228:Vessel [Tissue]
   755 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "stained with periodic acid-Schiff"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   883   C0440048:Periodic acid Schiff stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Periodic acid schiff
   883   C0523213:Periodic acid-Schiff stain [Laboratory Procedure]
   806   C0031068:Periodic Acid [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0332182:Periodic [Temporal Concept]
   760   C1706381:PERIODIC [Intellectual Product]
   760   C2949227:Schiff [Pharmacologic Substance]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "hematoxylin for histologic evaluation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.60: Retinal cells, lesions, and capillary basement membrane thickness were quantified in a masked manner. 

Phrase: "Retinal cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C2338017:Retinal cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "lesions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0221198:lesions [Finding]
   966 E C1546698:Lesion [Intellectual Product]

Phrase: "and"

Phrase: "capillary basement membrane thickness"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1280412:Thickness [Qualitative Concept]

Phrase: "were"

Phrase: "quantified in a masked manner."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0150108:masked [Research Activity]
   760   C0150112:MASKED [Functional Concept]
   760   C1555580:masked [Idea or Concept]
   726   C1709793:Quantify [Quantitative Concept]
Processing 00000000.tx.61: The number of pericyte "ghosts" (indicating a site on a capillary where a pericyte had been lost) were determined in the mid-retina by examining 1,300 capillary cells per retina. 

Phrase: "The number of pericyte """
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "ghosts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014776:ghost [Cell Component]

Phrase: """"

Phrase: "("

Phrase: "indicating"

Phrase: "a site on a capillary where"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205145:Site [Spatial Concept]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]

Phrase: "a pericyte"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598800:Pericyte [Cell]

Phrase: "had"

Phrase: "been"

Phrase: "lost"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0745777:Lost [Functional Concept]

Phrase: ")"

Phrase: "were"

Phrase: "determined in the mid-retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035298:Retina [Body Part, Organ, or Organ Component]
   760   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "by examining 1,300 capillary cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "per retina."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035298:Retina [Body Part, Organ, or Organ Component]
  1000   C1278894:Retina [Body Part, Organ, or Organ Component]
Processing 00000000.tx.62: The number of acellular capillaries was counted in multiple mid-retinal fields (one field adjacent to each of the five to seven retinal arterioles radiating from the optic disc) and expressed relative to retinal area examined. 

Phrase: "The number of acellular capillaries"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "was"

Phrase: "counted in multiple mid-retinal fields"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0035298:Retinal [Body Part, Organ, or Organ Component]
   753   C0439064:Multiple [Quantitative Concept]
   719   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   719   C0750480:Count [Activity]
   719   C1521738:Field [Conceptual Entity]
   719   C1705566:Count [Quantitative Concept]
   719   C2346620:Field [Conceptual Entity]
   719   C2349184:Field [Conceptual Entity]
   719   C3539073:FIELD [Spatial Concept]

Phrase: "(one field"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   861   C1521738:Field [Conceptual Entity]
   861   C2346620:Field [Conceptual Entity]
   861   C2349184:Field [Conceptual Entity]
   861   C3539073:FIELD [Spatial Concept]

Phrase: "adjacent to each of the five to seven retinal arterioles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205117:Adjacent to [Spatial Concept]
           Adjacent

Phrase: "radiating from the optic disc"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0029127:Optic Disk [Body Part, Organ, or Organ Component]
   760   C0015392:Optic [Body Part, Organ, or Organ Component]
   760   C0029144:optic [Occupation or Discipline]
   760   C0180459:DISC [Medical Device]
   760   C0332301:radiating [Functional Concept]
   760   C1556138:Disc [Body Part, Organ, or Organ Component]
   760   C1705229:Disc [Medical Device]
   760   C2348299:Disc [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "expressed relative to retinal area"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.63: Pericyte ghosts were counted only on capillaries that had one or more endothelial cells, because capillaries that lacked pericytes as well as endothelial cells were by definition acellular. 

Phrase: "Pericyte ghosts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014776:ghosts [Cell Component]

Phrase: "were"

Phrase: "counted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: "only on capillaries"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0006901:Capillaries [Body Part, Organ, or Organ Component]
   790   C0205171:Only [Quantitative Concept]
   790   C0935624:Capillaries [Body Part, Organ, or Organ Component]
   790   C1720467:Only [Intellectual Product]
   756 E C1280521:Capillary [Body Part, Organ, or Organ Component]

Phrase: "that"

Phrase: "had"

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "or"

Phrase: "more endothelial cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0225336:Endothelial Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "because"

Phrase: "capillaries"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0006901:Capillaries [Body Part, Organ, or Organ Component]
  1000   C0935624:Capillaries [Body Part, Organ, or Organ Component]
   966 E C1280521:Capillary [Body Part, Organ, or Organ Component]

Phrase: "that lacked pericytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0598800:Pericytes [Cell]

Phrase: "as well as"

Phrase: "endothelial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0225336:Endothelial Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were by definition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1550452:definition [Idea or Concept]
   790   C1704788:Definition [Conceptual Entity]
   790   C3539107:Definition [Intellectual Product]

Phrase: "acellular."
Processing 00000000.tx.64: The methods of counting pericyte ghosts differed between the two experiments, resulting in different absolute numbers even though the conclusions were the same. 

Phrase: "The methods of counting pericyte ghosts"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0025663:Methods [Intellectual Product]
   753   C0025664:methods [Intellectual Product]
   753   C0449851:Methods [Functional Concept]
   719 E C0871511:METHOD [Intellectual Product]

Phrase: "differed between the two experiments,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0205448:Two [Quantitative Concept]
   760   C0681814:Experiments [Research Activity]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "resulting in different absolute numbers even"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C0332294:Resulting in [Functional Concept]
   753   C0205344:Absolute [Qualitative Concept]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]
   753   C0678226:resulting [Functional Concept]
   753   C1705242:Different [Qualitative Concept]
   719 E C1274040:Result [Functional Concept]
   719 E C1546471:Result [Idea or Concept]
   719 E C2825142:Result [Finding]

Phrase: "though"

Phrase: "the conclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusions [Idea or Concept]

Phrase: "were"

Phrase: "the same."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445247:Same [Qualitative Concept]
Processing 00000000.tx.65: In the vitamins E+C experiment, pericyte ghosts were counted while the vascular preparation was viewed at high magnification (400x) in the microscope; 

Phrase: "In the vitamins E+C experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0681814:Experiment [Research Activity]
   812   C1706386:Experiment [Conceptual Entity]
   741 E C1517586:Experimental [Qualitative Concept]

Phrase: "pericyte ghosts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014776:ghosts [Cell Component]

Phrase: "were"

Phrase: "counted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: "while"

Phrase: "the vascular preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0455052:Preparation [Health Care Activity]
   861   C1521827:Preparation [Functional Concept]

Phrase: "was"

Phrase: "viewed at high magnification"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   802   C1508435:View magnification [Spatial Concept]
   770   C0205250:High [Qualitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C2700149:HIGH [Intellectual Product]
   737   C0449911:View [Spatial Concept]

Phrase: "(400x"

Phrase: ")"

Phrase: "in the microscope"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0181839:Microscope [Medical Device]
  1000   C1706379:Microscope [Medical Device]

Phrase: ";"
Processing 00000000.tx.66: in the multi-antioxidant experiment, areas of the vascular bed were systematically photographed at the same magnification, and ghosts were determined by examination of digital images. 

Phrase: "in the multi-antioxidant experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0681814:Experiment [Research Activity]
   827   C1706386:Experiment [Conceptual Entity]
   755 E C1517586:Experimental [Qualitative Concept]

Phrase: "areas of the vascular bed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C0558274:Bed area [Spatial Concept]
   760   C0205146:areas [Spatial Concept]
   726 E C0017446:Area [Geographic Area]

Phrase: "were"

Phrase: "systematically"

Phrase: "photographed at the same magnification,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0445247:Same [Qualitative Concept]
   726   C0441468:photograph [Manufactured Object]

Phrase: "and"

Phrase: "ghosts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014776:ghosts [Cell Component]

Phrase: "were"

Phrase: "determined by examination of digital images."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0562246:Examination of finger [Diagnostic Procedure]
   783   C0199220:Digital examination [Diagnostic Procedure]
   753   C0442015:Digital [Intellectual Product]
   753   C1883674:Digital [Qualitative Concept]
   719   C1704254:Image [Intellectual Product]
   719   C1704922:Image [Entity]
   719   C3542466:Image [Intellectual Product]
Processing 00000000.tx.67: Ghosts could be seen clearly in the microscope, but the digital method allowed us to mark positively each ghost and cell observed on the image (and to refer to the microscope for structure where the decision to classify the object as a ghost was more difficult). 

Phrase: "Ghosts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014776:ghosts [Cell Component]

Phrase: "could"

Phrase: "be"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "clearly in the microscope,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0181839:Microscope [Medical Device]
   770   C1706379:Microscope [Medical Device]

Phrase: "but"

Phrase: "the digital method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mark"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:mark [Qualitative Concept]

Phrase: "positively"

Phrase: "each ghost"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014776:ghost [Cell Component]

Phrase: "and"

Phrase: "cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "observed on the image"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1441672:Observed [Functional Concept]
   770   C1704254:Image [Intellectual Product]
   770   C1704922:Image [Entity]
   770   C3542466:Image [Intellectual Product]

Phrase: "("

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "refer to the microscope"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0181839:Microscope [Medical Device]
   770   C0205543:refer [Functional Concept]
   770   C1706379:Microscope [Medical Device]

Phrase: "for structure where"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "the decision to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679006:Decision [Mental Process]

Phrase: "classify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008902:classify [Classification]

Phrase: "the object as a ghost"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0347997:Object [Physical Object]
   760   C1518526:Object [Conceptual Entity]
   760   C1704861:Object [Conceptual Entity]

Phrase: "was"

Phrase: "more difficult"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: ")."
Processing 00000000.tx.68: The difference in the absolute numbers of ghosts detected in the two studies presumably reflects these differences. 

Phrase: "The difference in the absolute numbers of ghosts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1705241:*Difference [Quantitative Concept]
   744   C1705242:Difference [Qualitative Concept]

Phrase: "detected in the two"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205448:Two [Quantitative Concept]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "presumably"

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "these differences."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.69: Capillary basement membrane width was determined in the superior portion of the retina (mid-retina of the right eye) for representative animals using the method of Siperstein et al. 

Phrase: "Capillary basement membrane width"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0487742:Width [Quantitative Concept]
   741 E C0332464:Wide [Spatial Concept]

Phrase: "was"

Phrase: "determined in the superior portion of the retina"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0035298:Retina [Body Part, Organ, or Organ Component]
   744   C0449719:Portion [Spatial Concept]
   744   C1278894:Retina [Body Part, Organ, or Organ Component]
   744   C1282910:Superior [Spatial Concept]

Phrase: "(mid-retina of the right eye"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   858   C0229199:Retina of right eye [Body Part, Organ, or Organ Component]
           Retina, right eye
           Retina.right
   858   C1289040:Retina of right eye [Body Part, Organ, or Organ Component]
   783   C0229201:eye retina [Body Part, Organ, or Organ Component]
   783   C0459649:EYE, RETINA [Body Part, Organ, or Organ Component]
   753   C0035298:Retina [Body Part, Organ, or Organ Component]
   753   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "for representative animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the method of Siperstein et al."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0025663:Method [Intellectual Product]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.70: (26). 

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.71: Statistical analysis. 

Phrase: "Statistical analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.72: Data are reported as means  SD and analyzed statistically using the nonparametric Kruskal-Wallis test followed by the Mann-Whitney U test for multiple-group comparisons. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "reported as means  SD"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C1704970:Means [Conceptual Entity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]
   737 E C3273238:Report [Intellectual Product]

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "statistically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038215:Statistically [Occupation or Discipline]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the nonparametric Kruskal-Wallis test"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1708614:Kruskal-Wallis Test [Intellectual Product]
   902   C1709255:Non-Parametric Test [Intellectual Product]
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]

Phrase: "followed by the Mann-Whitney U test"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   853   C0242927:Mann-Whitney U Test [Quantitative Concept]
   804   C1708930:Mann-Whitney Test [Intellectual Product]
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0022885:Test [Laboratory Procedure]
   748   C0039593:Test [Functional Concept]
   748   C0392366:test [Intellectual Product]
   714 E C1719822:Follow [Intellectual Product]

Phrase: "for multiple-group comparisons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1707455:Comparison [Activity]
Processing 00000000.tx.73: Similar conclusions were reached also by using analysis of variance (ANOVA) followed by Tukeys test.  

Phrase: "Similar conclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707478:Conclusions [Idea or Concept]

Phrase: "were"

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "also by using analysis of variance (ANOVA)"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   833   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   767   C1524063:Use of [Functional Concept]
           Using
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   753   C1711260:Variance [Qualitative Concept]
   753   C2348152:Variance [Quantitative Concept]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "followed by Tukeys test."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0022885:Test [Laboratory Procedure]
   770   C0039593:Test [Functional Concept]
   770   C0392366:test [Intellectual Product]
   737 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.74: RESULTS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Average blood hexose concentrations, as measured by GHb, did not differ between the two experiments and are therefore pooled. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Average blood hexose concentrations,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   886   C2827768:Average Concentration [Quantitative Concept]
   875   C0427728:blood concentrations [Laboratory or Test Result]
   875   C0699870:blood concentrations [Quantitative Concept]
   875   C1313904:blood concentrations [Laboratory Procedure]
   812   C0086045:Concentrations [Mental Process]
   779 E C1446561:Concentration [Quantitative Concept]
   729 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "as"

Phrase: "measured by GHb,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0000503:GHB [Organic Chemical,Pharmacologic Substance]
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "differ between the two experiments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0205448:Two [Quantitative Concept]
   760   C0681814:Experiments [Research Activity]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "and"

Phrase: "are"

Phrase: "therefore"

Phrase: "pooled."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1709595:Pooled [Conceptual Entity]
  1000   C2349200:Pooled [Functional Concept]
   966 E C0337051:Pool [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]
Processing 00000000.tx.75: GHb remained significantly (P < 0.001) greater than normal in all of the diabetic groups and galactose-fed groups throughout the study (averaging 4.0  0.6 for the normal group, 12.5  0.8 for diabetic rats, 13.3  2.2 for diabetic rats treated with antioxidants, 6.3  0.9 for galactosemic controls, and 6.2  0.5 for galactosemic rats treated with antioxidants). 

Phrase: "GHb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000503:GHB [Organic Chemical,Pharmacologic Substance]

Phrase: "remained"

Phrase: "significantly"

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "greater than normal"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0439093:Greater Than [Quantitative Concept]
   790   C0443228:greater [Quantitative Concept]
   790   C1704243:Greater [Quantitative Concept]
   756 E C0549177:Great [Quantitative Concept]

Phrase: "in all"

Phrase: "of the diabetic groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "galactose-fed groups throughout the study"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1552839:groups [Idea or Concept]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]

Phrase: "("

Phrase: "averaging"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1510992:Average [Quantitative Concept]
   966   C2825518:AVERAGE [Quantitative Concept]

Phrase: "4.0  0.6 for the normal group,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   767   C0441876:Group 4 [Intellectual Product]
   744   C0205307:Normal [Qualitative Concept]
   744   C0439166:% normal [Quantitative Concept]
   744   C0441833:Group [Idea or Concept]
   744   C0687744:group [Population Group]
   744   C1257890:Group [Population Group]
   744   C1552516:Group [Health Care Related Organization]
   744   C1705428:Group [Conceptual Entity]
   744   C1705429:Group [Population Group]
   744   C2347086:% Normal [Quantitative Concept]

Phrase: "12.5  0.8 for diabetic rats,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0444499:0/5 [Quantitative Concept]
   748   C0034693:rats [Mammal]
   748   C0034721:Rats [Mammal]
   748   C0241863:DIABETIC [Finding]

Phrase: "13.3  2.2 for diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0034693:rats [Mammal]
   748   C0034721:Rats [Mammal]
   748   C0241863:DIABETIC [Finding]

Phrase: "treated with antioxidants,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0003402:Antioxidants [Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "6.3  0.9 for galactosemic controls,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1630409:6/3 [Finding]
   774   C0442751:6 9 [Finding]
   714   C0243148:control [Qualitative Concept]
   714   C1550141:Control [Substance]
   714   C1882979:Control [Conceptual Entity]
   714   C2587213:Control [Functional Concept]
   714   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "6.2  0.5 for galactosemic rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0444499:0/5 [Quantitative Concept]
   774   C0442749:6/5 [Finding]
   748   C0034693:rats [Mammal]
   748   C0034721:Rats [Mammal]

Phrase: "treated with antioxidants"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0003402:Antioxidants [Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: ")."
Processing 00000000.tx.76: Neither antioxidant supplement had a significant effect on GHb, urine volume, or body weight compared with that in control diabetic rats or galactose-fed rats. 

Phrase: "Neither antioxidant supplement"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0242295:Supplement [Food]
   861   C1947943:Supplement [Intellectual Product]
   861   C2348609:Supplement [Functional Concept]

Phrase: "had"

Phrase: "a significant effect on GHb,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "urine volume,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0232856:Urine volume [Clinical Attribute]
  1000   C1278293:Urine volume [Laboratory Procedure]
  1000   C1287298:Urine volume [Finding]
   861   C0042036:Urine [Body Substance]
   861   C0042037:urine [Functional Concept]
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]
   861   C2963137:Urine [Body Substance]

Phrase: "or"

Phrase: "body weight"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0005910:Body Weight [Organism Attribute]
           weight
  1000   C1305866:body weight [Diagnostic Procedure]
           weight
   861   C0043100:Weight [Quantitative Concept]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   861   C1705104:Weight [Idea or Concept]
   777 E C1995017:Bodies [Cell Component]

Phrase: "compared with that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "in control diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C0241863:DIABETIC [Finding]

Phrase: "or"

Phrase: "galactose-fed rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
Processing 00000000.tx.77: Oxidative stress, as estimated by TBARS, remained elevated (twofold above normal) in the retina of rats that were diabetic or experimentally galactosemic for at least 1 year. 

Phrase: "Oxidative stress,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "as"

Phrase: "estimated by TBARS,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0001128:acid substances [Chemical]
           Acid
   806   C0076442:thiobarbituric acid [Organic Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0439861:Substances [Substance]
   760   C0750572:Estimated [Quantitative Concept]

Phrase: "remained"

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "(twofold above normal"

Phrase: ")"

Phrase: "in the retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035298:Retina [Body Part, Organ, or Organ Component]
  1000   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "of rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "that"

Phrase: "were"

Phrase: "diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "or"

Phrase: "experimentally galactosemic for"

Phrase: "at least 1 year."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439234:year [Temporal Concept]
   827   C0439508:/year [Temporal Concept]
Processing 00000000.tx.78: Likewise, total PKC activity in the whole retina remained increased above normal (35%), and NO remained elevated >50% above normal in both diabetic and galactosemic animals (Table 1). 

Phrase: "Likewise,"

Phrase: "total PKC activity in the whole retina"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   818   C1150572:protein kinase C activity [Molecular Function]
   784   C1150527:protein kinase activity [Molecular Function]
   784   C3642159:Protein C Activity [Laboratory Procedure]
   766 E C2261495:protein phosphokinase activity [Molecular Function]
   762   C1150423:kinase activity [Molecular Function]
   762   C1537044:protein activity [Molecular Function]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "remained"

Phrase: "increased above normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205307:Normal [Qualitative Concept]
   827   C0439166:% normal [Quantitative Concept]
   827   C2347086:% Normal [Quantitative Concept]

Phrase: "(35%"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "NO"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0028128:nitric oxides [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:Oxides [Inorganic Chemical]
   827 E C2986642:oxide [Chemical Viewed Functionally]

Phrase: "remained"

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: ">50% above normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205307:Normal [Qualitative Concept]
   790   C0439166:% normal [Quantitative Concept]
   790   C2347086:% Normal [Quantitative Concept]

Phrase: "in both diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "galactosemic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.79: View this table: [in this window] [in a new window]  TABLE 1 Administration of multi-antioxidants inhibited hyperglycemia-induced elevation in retinal TBARS, NO, and PKC  Microvascular lesions consistent with the early stages of diabetic retinopathy were present in diabetic control and galactose control rats after at least 1 year of elevated hexose concentration (P < 0.01 vs. normal controls; Figs. 1 and 2). 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 1 Administration of multi-antioxidants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0001554:Administration [Occupational Activity]
   753   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "hyperglycemia-induced elevation in retinal TBARS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0439775:Elevation [Therapeutic or Preventive Procedure]
   744   C0702240:Elevation [Spatial Concept]

Phrase: "NO,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0028128:nitric oxides [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:Oxides [Inorganic Chemical]
   827 E C2986642:oxide [Chemical Viewed Functionally]

Phrase: "and"

Phrase: "PKC  Microvascular lesions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0221198:lesions [Finding]
   771 E C1546698:Lesion [Intellectual Product]
   717   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "consistent with the early stages of diabetic retinopathy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "were"

Phrase: "present in diabetic control"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "galactose control rats"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "after at least 1 year of elevated hexose concentration"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   742   C0019494:Hexose [Carbohydrate]
   742   C0086045:Concentration [Mental Process]
   742   C0205250:Elevated [Qualitative Concept]
   742   C0231290:After [Temporal Concept]
   742   C0439234:year [Temporal Concept]
   742   C0439508:/year [Temporal Concept]
   742   C0687676:After [Temporal Concept]
   742   C1446561:Concentration [Quantitative Concept]
   742   C3163633:Elevated [Qualitative Concept]

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. normal controls"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   966   C2705716:normal control [Qualitative Concept]
   861   C0205307:Normal [Qualitative Concept]
   861   C0439166:% normal [Quantitative Concept]
   861   C2347086:% Normal [Quantitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "; Figs. 1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.80: Lesions included pericyte ghosts, acellular capillaries, and thickened retinal capillary basement membrane. 

Phrase: "Lesions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221198:Lesion [Finding]
  1000   C1546698:Lesion [Intellectual Product]

Phrase: "included pericyte ghosts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014776:ghosts [Cell Component]

Phrase: "acellular capillaries,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0006901:Capillaries [Body Part, Organ, or Organ Component]
   861   C0935624:Capillaries [Body Part, Organ, or Organ Component]
   827 E C1280521:Capillary [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "thickened retinal capillary basement membrane."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   840   C0004799:Basement membrane [Tissue]
   804   C0006901:Capillary [Body Part, Organ, or Organ Component]
   804   C0025255:Membrane [Tissue]
   804   C0596901:Membrane [Cell Component]
   804   C0935624:Capillary [Body Part, Organ, or Organ Component]
   804   C1280521:Capillary [Body Part, Organ, or Organ Component]
   804   C1706182:Membrane [Manufactured Object]
   804   C1979853:Basement [Cell Component]
   733 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.81: Saccular capillary microaneurysms, intraretinal microvascular abnormalities, hemorrhages, and neovascularization were not observed in any group. 

Phrase: "Saccular capillary microaneurysms,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333101:Microaneurysms [Anatomical Abnormality,Disease or Syndrome]

Phrase: "intraretinal microvascular abnormalities,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   966   C1306674:Intraretinal microvascular abnormality [Disease or Syndrome]
   827   C0000768:Abnormalities [Congenital Abnormality]
   827   C0000769:abnormalities [Functional Concept]
   827   C0443258:Microvascular [Functional Concept]
   793 E C1704258:Abnormality [Finding]
   743 E C0205161:Abnormal [Qualitative Concept]
   743 E C2347472:% Abnormal [Quantitative Concept]
   743 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "hemorrhages,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019080:HEMORRHAGES [Pathologic Function]

Phrase: "and"

Phrase: "neovascularization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027686:Neovascularisation [Pathologic Function]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed in any group."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1441672:Observed [Functional Concept]
   770   C1552516:Group [Health Care Related Organization]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
Processing 00000000.tx.82: View larger version (19K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.83: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.84: Supplementation with vitamins C+E significantly inhibited acellular capillaries in diabetic rats and tended to inhibit formation of pericyte ghosts but had no effect on any lesions in experimentally galactosemic rats. 

Phrase: "Supplementation with vitamins C+E significantly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0302837:supplementation vitamins [Pharmacologic Substance]
   753   C0242297:Supplementation [Therapeutic or Preventive Procedure]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "acellular capillaries in diabetic rats"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0006901:Capillaries [Body Part, Organ, or Organ Component]
   760   C0935624:Capillaries [Body Part, Organ, or Organ Component]
   726 E C1280521:Capillary [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "tended"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "formation of pericyte ghosts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "but"

Phrase: "had"

Phrase: "no effect on any"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1301751:No effect [Qualitative Concept]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "lesions in experimentally galactosemic rats."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0221198:Lesion [Finding]
   760   C1546698:Lesion [Intellectual Product]
Processing 00000000.tx.85: Each bar represents mean  SD of 710 rats. 

Phrase: "Each bar"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "mean  SD of 710 rats."
Processing 00000000.tx.86: *P < 0.05 vs. normal controls; 

Phrase: "*P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. normal controls"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   966   C2705716:normal control [Qualitative Concept]
   861   C0205307:Normal [Qualitative Concept]
   861   C0439166:% normal [Quantitative Concept]
   861   C2347086:% Normal [Quantitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.87: **P < 0.05 vs. respective untreated diabetic rats or untreated galactose-fed rats.  

Phrase: "*"

Phrase: "*P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. respective untreated diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
   812   C0241863:DIABETIC [Finding]

Phrase: "or"

Phrase: "untreated galactose-fed rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
Processing 00000000.tx.88: View larger version (18K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.89: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.90: Administration of multi-antioxidant mixture significantly inhibited the development of both acellular capillaries and pericyte ghosts in retinas of diabetic rats and experimentally galactosemic rats. 

Phrase: "Administration of multi-antioxidant mixture significantly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0001554:Administration [Occupational Activity]
   753   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the development of both acellular capillaries"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243107:development [Physiologic Function]
   753   C0678723:Development [Organism Function]
   753   C1527148:Development [Functional Concept]

Phrase: "and"

Phrase: "pericyte ghosts in retinas of diabetic rats"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0014776:ghosts [Cell Component]

Phrase: "and"

Phrase: "experimentally galactosemic rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
Processing 00000000.tx.91: Each bar represents the mean  SD of 79 rats. 

Phrase: "Each bar"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the mean  SD of 79 rats."
Processing 00000000.tx.92: *P < 0.05 vs. normal; 

Phrase: "*P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.93: **P < 0.05 vs. respective untreated diabetic rats or untreated galactose-fed rats.  

Phrase: "*"

Phrase: "*P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. respective untreated diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
   812   C0241863:DIABETIC [Finding]

Phrase: "or"

Phrase: "untreated galactose-fed rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
Processing 00000000.tx.94: Dietary supplementation with vitamins C+E. 

Phrase: "Dietary supplementation with vitamins C+E."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0242297:Dietary Supplementation [Therapeutic or Preventive Procedure]
           Supplementation
   783   C0302837:supplementation vitamins [Pharmacologic Substance]
Processing 00000000.tx.95: Administration of vitamins C+E for 18 months significantly inhibited the development of acellular capillaries in retinas of diabetic rats (P < 0.05; Fig. 1). 

Phrase: "Administration of vitamins C+E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0001554:Administration [Occupational Activity]
   760   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "for 18 months significantly"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439231:months [Temporal Concept]
   793 E C0439507:/month [Temporal Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the development of acellular capillaries"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]

Phrase: "in retinas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035298:Retinas [Body Part, Organ, or Organ Component]
   966 E C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "of diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.96: In the same vitamins C+Etreated diabetic rats, the number of pericyte ghosts likewise tended to be inhibited, but the results did not achieve statistical significance. 

Phrase: "In the same vitamins C+Etreated diabetic rats,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0034693:rats [Mammal]
   799   C0034721:Rats [Mammal]
   799   C0241863:DIABETIC [Finding]

Phrase: "the number of pericyte ghosts likewise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "tended"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: ","

Phrase: "but"

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "achieve"

Phrase: "statistical significance."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:Statistical Significance [Quantitative Concept]
           Significance
  1000   C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistical [Occupation or Discipline]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.97: A diabetes-induced thickening of capillary basement membrane was not affected by this vitamin mixture (capillary basement membrane width for normals = 135  18 nm, diabetes = 215  51 nm, diabetes+vitamins C+E = 192  44 nm). 

Phrase: "A diabetes-induced thickening of capillary basement membrane"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0544995:Basement membrane thickening [Cell or Molecular Dysfunction]
   744   C0205400:Thickening [Finding]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by this vitamin mixture"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]
   760   C0392760:Affected [Functional Concept]
   760   C0439962:Mixture [Substance]
   760   C1314939:Affected [Functional Concept]
   726 E C0001721:Affect [Mental Process]

Phrase: "(capillary basement membrane width for normals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0487742:Width [Quantitative Concept]

Phrase: "= 135  18 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "= 215  51 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "diabetes+vitamins C+E = 192  44 nm)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0312860:NM [Cell Function]
Processing 00000000.tx.98: Supplementation with this dose of vitamins C+E had no beneficial effect on the development of any parameter of retinopathy in galactose-fed animals, including acellular capillaries, pericyte ghosts, and basement membrane thickness. 

Phrase: "Supplementation with this dose of vitamins C+E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0302837:supplementation vitamins [Pharmacologic Substance]
   744   C0242297:Supplementation [Therapeutic or Preventive Procedure]

Phrase: "had"

Phrase: "no beneficial effect on the development of any parameter of retinopathy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C1301751:No effect [Qualitative Concept]
   738   C1280500:Effect [Qualitative Concept]
   738   C2348382:Effect [Qualitative Concept]

Phrase: "in galactose-fed animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "acellular capillaries,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0006901:Capillaries [Body Part, Organ, or Organ Component]
   861   C0935624:Capillaries [Body Part, Organ, or Organ Component]
   827 E C1280521:Capillary [Body Part, Organ, or Organ Component]

Phrase: "pericyte ghosts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014776:ghosts [Cell Component]

Phrase: "and"

Phrase: "basement membrane thickness."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1280412:Thickness [Qualitative Concept]
   734   C0004799:Basement membrane [Tissue]
Processing 00000000.tx.99: This may be because the galactose-fed animals that received this vitamin mixture did not consume as much of the antioxidants as did the diabetic rats (due to hyperphagia in the diabetic rats); 

Phrase: "This"

Phrase: "may"

Phrase: "be"

Phrase: "because"

Phrase: "the galactose-fed animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "that"

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "this vitamin mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:Mixture [Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "consume"

Phrase: "as"

Phrase: "much of the antioxidants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0003402:Antioxidants [Pharmacologic Substance]

Phrase: "as"

Phrase: "did"

Phrase: "the diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "("

Phrase: "due to hyperphagia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020505:Hyperphagia [Mental or Behavioral Dysfunction]

Phrase: "in the diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.100: average supplemental intake of -tocopherol and ascorbic acid was 142  24 and 1,422  236 mg  kg-1 body wt  day-1, respectively, for the vitamins C+Etreated diabetic animals and 69  9 and 685  88 mg  kg-1 body wt  day-1, respectively, for the vitamins C+Etreated galactose-fed animals. 

Phrase: "average supplemental intake of -tocopherol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0087096:Tocopherol [Lipid,Pharmacologic Substance,Vitamin]
   804   C3255108:Tocopherol [Pharmacologic Substance]

Phrase: "and"

Phrase: "ascorbic acid"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0003968:Ascorbic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   944 E C0699147:Cecon [Carbohydrate,Pharmacologic Substance,Vitamin]
   944 E C0699151:Cenolate [Carbohydrate,Pharmacologic Substance,Vitamin]
   944 E C0699153:Cevalin [Carbohydrate,Pharmacologic Substance,Vitamin]
   916 E C2349136:Vitamin C [Organic Chemical,Vitamin]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "was"

Phrase: "142  24"

Phrase: "and"

Phrase: "1,422  236 mg  kg-1 body wt  day-1,"
Meta Candidates (Total=22; Excluded=1; Pruned=0; Remaining=21)
   880   C1442449:1 Day [Temporal Concept]
   850   C0439400:mg/kg/day [Quantitative Concept]
   846   C0439422:mg day [Quantitative Concept]
   846   C0439423:mg/day [Quantitative Concept]
   835   C0439418:kg/day [Quantitative Concept]
   824   C0333746:MG body [Finding]
   804   C0439272:mg kg [Quantitative Concept]
   790   C0022718:KG [Geographic Area]
   790   C0242821:body [Human]
   790   C0332173:/day [Temporal Concept]
   790   C0439209:kg [Quantitative Concept]
   790   C0439228:day [Temporal Concept]
   790   C0439269:mg% [Quantitative Concept]
   790   C0439505:/day [Temporal Concept]
   790   C0460148:Body [Anatomical Structure]
   790   C1268086:Body [Anatomical Structure]
   790   C1960952:mg % [Quantitative Concept]
   790   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   790   C2700323:WT [Fish]
   790   C2827734:1+ [Quantitative Concept]
   790   C2981698:1+ [Classification]
   706 E C1995017:Bodies [Cell Component]

Phrase: "respectively,"

Phrase: "for the vitamins C+Etreated diabetic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0003062:Animals [Animal]

Phrase: "and"

Phrase: "69  9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450388:69 [Intellectual Product]

Phrase: "and"

Phrase: "685  88 mg  kg-1 body wt  day-1,"
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   858   C0439400:mg/kg/day [Quantitative Concept]
   854   C0439422:mg day [Quantitative Concept]
   854   C0439423:mg/day [Quantitative Concept]
   842   C0439418:kg/day [Quantitative Concept]
   829   C0333746:MG body [Finding]
   807   C0439272:mg kg [Quantitative Concept]
   791   C0022718:KG [Geographic Area]
   791   C0242821:body [Human]
   791   C0332173:/day [Temporal Concept]
   791   C0439209:kg [Quantitative Concept]
   791   C0439228:day [Temporal Concept]
   791   C0439269:mg% [Quantitative Concept]
   791   C0439505:/day [Temporal Concept]
   791   C0460148:Body [Anatomical Structure]
   791   C1268086:Body [Anatomical Structure]
   791   C1960952:mg % [Quantitative Concept]
   791   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   791   C2700323:WT [Fish]
   708 E C1995017:Bodies [Cell Component]

Phrase: "respectively,"

Phrase: "for the vitamins C+Etreated galactose-fed animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0003062:Animals [Animal]
Processing 00000000.tx.101: Dietary supplementation with the multi-antioxidant mixture. 

Phrase: "Dietary supplementation with the multi-antioxidant mixture."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0242297:Dietary Supplementation [Therapeutic or Preventive Procedure]
           Supplementation
Processing 00000000.tx.102: Because diabetic rats consumed more food than experimentally galactosemic rats (20), the concentration of each antioxidant in the diet that was fed to galactosemic rats was increased by 50% (and adjusted periodically) in this experiment so that antioxidant intake (per kilogram of body weight per day) was comparable between antioxidant-treated diabetic rats and galactosemic rats. 

Phrase: "Because"

Phrase: "diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "consumed"

Phrase: "more food than experimentally galactosemic rats"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0016452:Food [Food]

Phrase: "(20"

Phrase: ")"

Phrase: ","

Phrase: "the concentration of each antioxidant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "in the diet"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0012155:Diet [Food]
  1000   C1442959:Diet [Organism Function]
  1000   C1519433:DIET [Therapeutic or Preventive Procedure]
  1000   C2983588:DIET [Food]
   928 E C2699635:DIETARY [Functional Concept]

Phrase: "that"

Phrase: "was"

Phrase: "fed to galactosemic rats"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C0342895:FED [Disease or Syndrome]
   737 E C0204695:Feed [Health Care Activity]
   737 E C2987508:Feed [Activity]

Phrase: "was"

Phrase: "increased by 50%"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "("

Phrase: "and"

Phrase: "adjusted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456081:Adjusted [Functional Concept]

Phrase: "periodically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332182:Periodically [Temporal Concept]

Phrase: ")"

Phrase: "in this experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that antioxidant intake"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1512806:Intake [Functional Concept]

Phrase: "("

Phrase: "per kilogram"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439209:Kilogram [Quantitative Concept]

Phrase: "of body weight"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0005910:Body Weight [Organism Attribute]
           weight
  1000   C1305866:body weight [Diagnostic Procedure]
           weight
   861   C0043100:Weight [Quantitative Concept]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   861   C1705104:Weight [Idea or Concept]
   777 E C1995017:Bodies [Cell Component]

Phrase: "per day"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332173:/day [Temporal Concept]
  1000   C0439228:day [Temporal Concept]
  1000   C0439505:/day [Temporal Concept]

Phrase: ")"

Phrase: "was"

Phrase: "comparable between antioxidant-treated diabetic rats"

Phrase: "and"

Phrase: "galactosemic rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.103: Administration of the multi-antioxidant mixture for the entire duration significantly inhibited the diabetes- and galactosemia-induced increases in retinal oxidative stress and also corrected hyperglycemia-induced increases in retinal PKC and NO (P < 0.05; Table 1). 

Phrase: "Administration of the multi-antioxidant mixture"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0001554:Administration [Occupational Activity]
   753   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "for the entire duration significantly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449238:Duration [Temporal Concept]
   827   C2926735:Duration [Pharmacologic Substance]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the diabetes-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "galactosemia-induced increases in retinal oxidative stress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:increases [Functional Concept]

Phrase: "and"

Phrase: "also corrected hyperglycemia-induced increases in retinal PKC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0442805:increases [Functional Concept]

Phrase: "and"

Phrase: "NO"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0028128:nitric oxides [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:Oxides [Inorganic Chemical]
   827 E C2986642:oxide [Chemical Viewed Functionally]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.104: Unlike findings in the rats that were fed the vitamins C+E supplement, the multi-antioxidant supplement significantly inhibited the development of acellular capillaries and pericyte ghosts (P < 0.05) in both diabetic rats and galactose-fed rats (Fig. 2).  

Phrase: "Unlike findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "in the rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "that"

Phrase: "were"

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "the vitamins C+E supplement,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   912   C3661607:Vitamin E supplement [Food]
   912   C3661608:Vitamin C supplement [Food]
   886   C0681579:Vitamin supplement [Food]
   812   C0242295:Supplement [Food]
   812   C1947943:Supplement [Intellectual Product]
   812   C2348609:Supplement [Functional Concept]

Phrase: "the multi-antioxidant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003402:Antioxidant [Pharmacologic Substance]
   861   C0439064:Multi [Quantitative Concept]

Phrase: "supplement"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0242295:Supplement [Food]
  1000   C1947943:Supplement [Intellectual Product]
  1000   C2348609:Supplement [Functional Concept]

Phrase: "significantly"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the development of acellular capillaries"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]

Phrase: "and"

Phrase: "pericyte ghosts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014776:ghosts [Cell Component]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in both diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "galactose-fed rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.105: DISCUSSION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  This study shows that increases in oxidative stress, PKC activation, and NO production remain elevated for at least 12 months in retinas of diabetic or galactosemic animals and can be inhibited significantly by the administration of antioxidants. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that increases in oxidative stress,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:increases [Functional Concept]

Phrase: "PKC activation,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C3546691:protein kinase C activation [Molecular Function]
   923   C1819041:protein kinase activation [Cell Function]
   902   C0599177:protein activation [Genetic Function]
   812   C1879547:Activation [Activity]
   756   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   708   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   708   C1168438:Protein C [Laboratory Procedure]
   708   C1418943:PROTEIN C [Gene or Genome]
   708   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "NO production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033268:production [Occupational Activity]
   734   C0028128:nitric oxides [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]

Phrase: "remain"

Phrase: "elevated for"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0205250:Elevated [Qualitative Concept]
   833   C3163633:Elevated [Qualitative Concept]

Phrase: "at least 12 months"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439231:months [Temporal Concept]
   793 E C0439507:/month [Temporal Concept]

Phrase: "in retinas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035298:Retinas [Body Part, Organ, or Organ Component]
   966 E C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "of diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "or"

Phrase: "galactosemic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "and"

Phrase: "can"

Phrase: "be"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "significantly by the administration of antioxidants."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0001554:Administration [Occupational Activity]
   753   C0003402:Antioxidants [Pharmacologic Substance]
   753   C1533734:Administration [Therapeutic or Preventive Procedure]
Processing 00000000.tx.106: Moreover, our results indicate that administration of antioxidants can inhibit the development of diabetes-induced retinal histopathology. 

Phrase: "Moreover,"

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that administration of antioxidants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0001554:Administration [Occupational Activity]
   770   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "can"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the development of diabetes-induced retinal histopathology."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C2610344:retinal development [Organ or Tissue Function]
   748   C0243107:development [Physiologic Function]
   748   C0678723:Development [Organism Function]
   748   C1527148:Development [Functional Concept]
Processing 00000000.tx.107: The results demonstrate that there is at least a strong association between hyperglycemia-induced oxidative stress and retinal histopathology. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that there"

Phrase: "is at least"

Phrase: "a strong association between hyperglycemia-induced oxidative stress"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "retinal histopathology."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243140:histopathology [Functional Concept]
   861   C0677043:Histopathology [Biomedical Occupation or Discipline]
Processing 00000000.tx.108: Possible sources of oxidative stress in diabetes include increased generation of reactive oxygen species by auto-oxidation of glucose, decreased tissue concentrations of low-molecular-weight antioxidants (13,27,28,29), and impaired activities of antioxidant defense enzymes (13). 

Phrase: "Possible sources of oxidative stress"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   844   C3258183:Sources of stress [Finding]
   760   C0449416:sources [Finding]
   726 E C1705919:Source [Idea or Concept]

Phrase: "in diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "increased generation of reactive oxygen species"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079411:Generation [Temporal Concept]
   753   C3146294:Generation [Activity]

Phrase: "by auto-oxidation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0311405:Auto-oxidation [Natural Phenomenon or Process]
   861   C0030011:Oxidation [Molecular Function]
   861   C1441488:Auto [Laboratory Procedure]

Phrase: "of glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "decreased tissue concentrations of low-molecular-weight antioxidants"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0086045:Concentrations [Mental Process]
   711 E C1446561:Concentration [Quantitative Concept]

Phrase: "(13,"

Phrase: "27,"

Phrase: "28,"

Phrase: "29"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "impaired activities of antioxidant defense enzymes"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   767   C1148564:antioxidant activity [Molecular Function]
   753   C0441655:Activities [Activity]
   750   C0243102:enzyme activity [Molecular Function]
   719 E C0205177:Activity [Functional Concept]
   719 E C0439167:% activity [Quantitative Concept]
   719 E C1561536:*Activity [Idea or Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.109: We reported previously that retinal glutathione levels are decreased and antioxidant defense enzymes are impaired in diabetes and that these defects are corrected by supplementation with either antioxidant mixture (13,20). 

Phrase: "We"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "that retinal glutathione levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "antioxidant defense enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014442:Enzymes [Enzyme,Organic Chemical]
   827   C0014445:enzymes [Functional Concept]

Phrase: "are"

Phrase: "impaired in diabetes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C0221099:Impaired [Functional Concept]
   790   C0684336:Impaired [Pathologic Function]

Phrase: "and"

Phrase: "that"

Phrase: "these defects"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0243067:defects [Functional Concept]
   966 E C1457869:Defect [Functional Concept]
   966 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "are"

Phrase: "corrected by supplementation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205202:Corrected [Qualitative Concept]
   790   C0242297:Supplementation [Therapeutic or Preventive Procedure]
   756 E C2349182:Correct [Qualitative Concept]

Phrase: "with either antioxidant mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439962:Mixture [Substance]

Phrase: "(13,"

Phrase: "20"

Phrase: ")."
Processing 00000000.tx.110: Which retinal cell types manifest the oxidative stress in diabetes cannot be identified in the present study because metabolic abnormalities were measured in the whole retina. 

Phrase: "Which retinal cell types"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0449475:Cell types [Intellectual Product]
   901   C2338017:Retinal cell [Cell]
   867 E C0007634:Cell Type [Cell]
           Cell
   827   C0332307:Types [Qualitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1547052:*Type [Quantitative Concept]

Phrase: "manifest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205319:Manifest [Functional Concept]

Phrase: "the oxidative stress in diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   760   C0038435:Stress [Finding]
   760   C0311404:Oxidative [Functional Concept]

Phrase: "cannot"

Phrase: "be"

Phrase: "identified in the present study"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0150312:Present [Quantitative Concept]
   760   C0205396:Identified [Qualitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C2603343:Study [Research Activity]

Phrase: "because"

Phrase: "metabolic abnormalities"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0000768:Abnormalities [Congenital Abnormality]
   861   C0000769:abnormalities [Functional Concept]
   827 E C1704258:Abnormality [Finding]
   777 E C0205161:Abnormal [Qualitative Concept]
   777 E C2347472:% Abnormal [Quantitative Concept]
   777 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "were"

Phrase: "measured in the whole retina."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0035298:Retina [Body Part, Organ, or Organ Component]
   760   C0444667:Whole [Quantitative Concept]
   760   C0444706:Measured [Qualitative Concept]
   760   C1278894:Retina [Body Part, Organ, or Organ Component]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.111: Reactive oxygen species have been reported to be increased in endothelial cell in the early stages of diabetes in BBZ/W rats, and this is accompanied by endothelial cell dysfunction (30). 

Phrase: "Reactive oxygen species"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "have"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "increased in endothelial cell"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0225336:Endothelial cell [Cell]
   770   C0007634:Cell [Cell]
   770   C0014257:Endothelial [Tissue]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]

Phrase: "in the early stages"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C2363430:early stages [Temporal Concept]
   983 E C1517886:Early Stage [Classification]
   861   C1306673:Stages [Qualitative Concept]
   827 E C0205390:Stage [Temporal Concept]
   827 E C1300072:Stage [Clinical Attribute]

Phrase: "of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "in BBZ/W rats,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "and"

Phrase: "this"

Phrase: "is"

Phrase: "accompanied by endothelial cell dysfunction"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0225336:Endothelial cell [Cell]
   797   C0856169:endothelial dysfunction [Disease or Syndrome]
   760   C0007634:Cell [Cell]
   760   C0014257:Endothelial [Tissue]
   760   C0031847:dysfunction [Functional Concept]
   760   C0277785:Dysfunction, NOS [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   704 E C0231174:Malfunction [Functional Concept]
   704 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.112: Li et al. 

Phrase: "Li et al."
Processing 00000000.tx.113: (31) observed alterations in levels of mRNA for antioxidant enzymes in retinal pericytes from diabetic patients. 

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: "observed alterations in levels of mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1515926:Alteration [Idea or Concept]

Phrase: "for antioxidant enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]

Phrase: "in retinal pericytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0598800:Pericytes [Cell]

Phrase: "from diabetic patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.114: Both antioxidant supplements inhibited oxidative stress (9,13,20) and vaso-obliteration of retinal capillaries (as reflected by the number of acellular capillaries) in diabetic animals, but only the multi-antioxidantsupplemented diet inhibited retinal histopathology in galactose-fed animals. 

Phrase: "Both antioxidant supplements"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0242295:Supplement [Food]
   827   C1947943:Supplement [Intellectual Product]
   827   C2348609:Supplement [Functional Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "(9,"

Phrase: "13,"

Phrase: "20"

Phrase: ")"

Phrase: "and"

Phrase: "vaso-obliteration of retinal capillaries"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332465:Obliteration [Functional Concept]
   760   C1293136:Obliteration [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: "as"

Phrase: "reflected by the number of acellular capillaries"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0006901:Capillaries [Body Part, Organ, or Organ Component]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]
   748   C0558058:reflected [Mental Process]
   748   C0935624:Capillaries [Body Part, Organ, or Organ Component]
   714 E C1280521:Capillary [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "in diabetic animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "but"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the multi-antioxidantsupplemented diet"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0012155:Diet [Food]
   827   C1442959:Diet [Organism Function]
   827   C1519433:DIET [Therapeutic or Preventive Procedure]
   827   C2983588:DIET [Food]
   755 E C2699635:DIETARY [Functional Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "retinal histopathology in galactose-fed animals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243140:histopathology [Functional Concept]
   753   C0677043:Histopathology [Biomedical Occupation or Discipline]
Processing 00000000.tx.115: This observation is consistent with evidence reported by us previously, showing that the multi-antioxidant diet corrected a galactose-induced decrease in retinal catalase activity (20) that was not corrected by supplementation with vitamins C+E (13). 

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "is"

Phrase: "consistent with evidence"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "reported by us previously,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C1709908:Reported By [Group]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the multi-antioxidant diet"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0012155:Diet [Food]
   827   C1442959:Diet [Organism Function]
   827   C1519433:DIET [Therapeutic or Preventive Procedure]
   827   C2983588:DIET [Food]
   755 E C2699635:DIETARY [Functional Concept]

Phrase: "corrected"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205202:Corrected [Qualitative Concept]
   966 E C2349182:Correct [Qualitative Concept]

Phrase: "a galactose-induced decrease in retinal catalase activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]

Phrase: "(20"

Phrase: ")"

Phrase: "that"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "corrected by supplementation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205202:Corrected [Qualitative Concept]
   790   C0242297:Supplementation [Therapeutic or Preventive Procedure]
   756 E C2349182:Correct [Qualitative Concept]

Phrase: "with vitamins C+E (13"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C0042874:Vitamin E [Lipid,Pharmacologic Substance,Vitamin]
   844   C0003968:Vitamin C [Organic Chemical,Pharmacologic Substance,Vitamin]
   844   C2349136:Vitamin C [Organic Chemical,Vitamin]
   812   C0042890:Vitamins [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: ")."
Processing 00000000.tx.116: It is not clear whether the beneficial effect of antioxidants in galactosemic animals that were fed the multi-antioxidant supplement is due to the greater intake of antioxidants in that experiment compared with that in the vitamins C+E experiment or whether the effect is due to benefits of the additional antioxidants. 

Phrase: "It"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "whether"

Phrase: "the beneficial effect of antioxidants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C3179302:Antioxidant Effect [Physiologic Function]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "in galactosemic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "that"

Phrase: "were"

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "the multi-antioxidant supplement"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0242295:Supplement [Food]
   827   C1947943:Supplement [Intellectual Product]
   827   C2348609:Supplement [Functional Concept]

Phrase: "is due to the greater intake of antioxidants"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0678226:Due to [Functional Concept]
           due
   744   C0003402:Antioxidants [Pharmacologic Substance]
   744   C0443228:greater [Quantitative Concept]
   744   C1512806:Intake [Functional Concept]
   744   C1704243:Greater [Quantitative Concept]
   744   C3146286:Due [Idea or Concept]
   711 E C0549177:Great [Quantitative Concept]

Phrase: "in"

Phrase: "that experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "compared with that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "in the vitamins C+E experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0681814:Experiment [Research Activity]
   812   C1706386:Experiment [Conceptual Entity]
   741 E C1517586:Experimental [Qualitative Concept]

Phrase: "or"

Phrase: "whether"

Phrase: "the effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "is due to benefits of the additional antioxidants."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0678226:Due to [Functional Concept]
           due
   744   C0003402:Antioxidants [Pharmacologic Substance]
   744   C0814225:Benefits [Quantitative Concept]
   744   C1524062:Additional [Functional Concept]
   744   C3146286:Due [Idea or Concept]
Processing 00000000.tx.117: Increasing the diversity of antioxidants in the diet has been shown to provide significantly more protection against oxidative stress in various organs than any individual antioxidant (32,33). 

Phrase: "Increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the diversity of antioxidants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880371:Diversity [Qualitative Concept]

Phrase: "in the diet"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0012155:Diet [Food]
  1000   C1442959:Diet [Organism Function]
  1000   C1519433:DIET [Therapeutic or Preventive Procedure]
  1000   C2983588:DIET [Food]
   928 E C2699635:DIETARY [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "significantly more protection against oxidative stress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1545588:Protection [Finding]

Phrase: "in various organs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0178784:organs [Body Part, Organ, or Organ Component]

Phrase: "than any individual antioxidant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003402:Antioxidant [Pharmacologic Substance]

Phrase: "(32,"

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.118: Vitamins C+E had effects similar to those observed with aminoguanidine, an agent that has antioxidant as well as other properties (34,35,36,37), in that it inhibited both parameters of oxidative stress and capillary lesions (acellular capillaries and pericyte ghosts) in diabetic rats but inhibited only oxidative stress in galactose-fed rats. 

Phrase: "Vitamins C+E"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   896   C0042874:Vitamin E [Lipid,Pharmacologic Substance,Vitamin]
   884   C0003968:Vitamin C [Organic Chemical,Pharmacologic Substance,Vitamin]
   884   C2349136:Vitamin C [Organic Chemical,Vitamin]

Phrase: "had"

Phrase: "effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "similar to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "observed with aminoguanidine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0282774:aminoguanidine [Organic Chemical,Pharmacologic Substance]
   790   C1441672:Observed [Functional Concept]

Phrase: "an agent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450442:Agent [Chemical Viewed Functionally]
  1000   C1254351:Agent [Pharmacologic Substance]
  1000   C1521826:Agent [Intellectual Product]

Phrase: "that"

Phrase: "has"

Phrase: "antioxidant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003402:Antioxidant [Pharmacologic Substance]

Phrase: "as well as"

Phrase: "other properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0871161:properties [Qualitative Concept]
  1000   C1292721:properties [Functional Concept]
   966 E C1882134:Property [Conceptual Entity]
   966 E C2347695:Property [Entity]

Phrase: "(34,"

Phrase: "35,"

Phrase: "36,"

Phrase: "37"

Phrase: ")"

Phrase: ","

Phrase: "in"

Phrase: "that"

Phrase: "it"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "both parameters of oxidative stress"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0449381:Parameters [Finding]
   726 E C0549193:Parameter [Spatial Concept]
   726 E C1704769:Parameter [Conceptual Entity]
   726 E C2350001:Parameter [Quantitative Concept]

Phrase: "and"

Phrase: "capillary lesions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0221198:lesions [Finding]
   827 E C1546698:Lesion [Intellectual Product]

Phrase: "(acellular capillaries"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0006901:Capillaries [Body Part, Organ, or Organ Component]
   861   C0935624:Capillaries [Body Part, Organ, or Organ Component]
   827 E C1280521:Capillary [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "pericyte ghosts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014776:ghosts [Cell Component]

Phrase: ")"

Phrase: "in diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "but"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "only oxidative stress in galactose-fed rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   748   C0038435:Stress [Finding]
   748   C0311404:Oxidative [Functional Concept]
Processing 00000000.tx.119: It is possible that both vitamins C+E and aminoguanidine have fewer antioxidant properties than the multi-antioxidant mixture, which may not be apparent from the parameters of oxidative stress that were measured. 

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "both vitamins C+E"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   896   C0042874:Vitamin E [Lipid,Pharmacologic Substance,Vitamin]
   884   C0003968:Vitamin C [Organic Chemical,Pharmacologic Substance,Vitamin]
   884   C2349136:Vitamin C [Organic Chemical,Vitamin]

Phrase: "and"

Phrase: "aminoguanidine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282774:aminoguanidine [Organic Chemical,Pharmacologic Substance]

Phrase: "have"

Phrase: "fewer antioxidant properties than the multi-antioxidant mixture,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   744   C0871161:properties [Qualitative Concept]
   744   C1292721:properties [Functional Concept]
   711 E C1882134:Property [Conceptual Entity]
   711 E C2347695:Property [Entity]

Phrase: "which"

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "apparent from the parameters of oxidative stress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0750489:apparent [Idea or Concept]

Phrase: "that"

Phrase: "were"

Phrase: "measured."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.120: Others have observed beneficial effects in peripheral nerve and heart at relatively high levels of the antioxidants (33,38). 

Phrase: "Others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "have"

Phrase: "observed beneficial effects in peripheral nerve"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "heart at relatively high levels of the antioxidants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0018787:Heart [Body Part, Organ, or Organ Component]
   744   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "(33,"

Phrase: "38"

Phrase: ")."
Processing 00000000.tx.121: Moreover, we cannot rule out the possibility that the antioxidants that were administered to hyperglycemic rats might have been acting via mechanisms in addition to those related to correction of oxidative stress. 

Phrase: "Moreover,"

Phrase: "we"

Phrase: "cannot"

Phrase: "rule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0805874:Rule [Idea or Concept]
  1000   C0870077:Rule [Intellectual Product]
  1000   C1446409:rule [Qualitative Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "the possibility"

Phrase: "that"

Phrase: "the antioxidants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003402:Antioxidants [Pharmacologic Substance]

Phrase: "that"

Phrase: "were"

Phrase: "administered to hyperglycemic rats"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C1521801:Administered [Functional Concept]
   737 E C1621583:Administer [Functional Concept]

Phrase: "might"

Phrase: "have"

Phrase: "been"

Phrase: "acting via mechanisms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0441712:Mechanisms [Functional Concept]
   756   C0079613:ACT [Therapeutic or Preventive Procedure]
   756 E C1706376:Mechanism [Manufactured Object]

Phrase: "in addition to those"

Phrase: "related to correction of oxidative stress."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   753   C0038435:Stress [Finding]
   753   C0311404:Oxidative [Functional Concept]
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]
   753   C1705565:CORRECTION [Intellectual Product]
   753   C1947976:Correction [Functional Concept]
   719 E C0163712:Relate [Organic Chemical]
Processing 00000000.tx.122: Inhibition of PKC might occur by multiple mechanisms, some of which might be independent of oxidative stress. 

Phrase: "Inhibition of PKC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "might"

Phrase: "occur by multiple mechanisms,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0439064:Multiple [Quantitative Concept]
   770   C0441712:Mechanisms [Functional Concept]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]
   737 E C1706376:Mechanism [Manufactured Object]

Phrase: "some of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205392:Some [Quantitative Concept]
   790   C3540770:Some [Intellectual Product]

Phrase: "might"

Phrase: "be independent of oxidative stress."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   806   C0332291:Independent of [Functional Concept]
   760   C0038435:Stress [Finding]
   760   C0085862:Independent [Idea or Concept]
   760   C0311404:Oxidative [Functional Concept]
   760   C1299583:Independent [Finding]
   760   C2987476:Be [Conceptual Entity]
Processing 00000000.tx.123: -Tocopherol has been found to normalize diabetes-induced increases in PKC activity via inhibition of diacylglycerol accumulation (a mechanism that seems not to involve oxidative stress) (39), but because reactive oxygen species directly increase the activity of PKC (40,41), it seems likely that oxidative stress also can contribute to activation of the enzyme. 

Phrase: "-Tocopherol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0087096:Tocopherol [Lipid,Pharmacologic Substance,Vitamin]
  1000   C3255108:Tocopherol [Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "normalize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalize [Research Activity]

Phrase: "diabetes-induced increases in PKC activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:increases [Functional Concept]

Phrase: "via inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of diacylglycerol accumulation"

Phrase: "("

Phrase: "a mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "seems"

Phrase: "not to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "involve"

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: ")"

Phrase: "(39"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "because"

Phrase: "reactive oxygen species directly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C0205332:Reactive [Qualitative Concept]
   812   C1705920:Species [Conceptual Entity]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the activity of PKC"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   864   C1150572:protein kinase C activity [Molecular Function]
   820   C1150527:protein kinase activity [Molecular Function]
   814   C3642159:Protein C Activity [Laboratory Procedure]
   802 E C2261495:protein phosphokinase activity [Molecular Function]
   783   C1150423:kinase activity [Molecular Function]
   783   C1537044:protein activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "(40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "41"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "seems"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that oxidative stress also"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   827   C0311404:Oxidative [Functional Concept]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "can"

Phrase: "contribute to activation of the enzyme."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0014429:Enzyme Activation [Molecular Function]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C1879547:Activation [Activity]
   753   C1880177:Contribute [Activity]
Processing 00000000.tx.124: Hyperglycemia-induced abnormalities of retinal PKC and oxidative stress are closely interrelated, as indicated further by evidence that normalization of PKC activity in diabetes with selective inhibitors can inhibit the diabetes-induced increase in free-radical accumulation (42,43). 

Phrase: "Hyperglycemia-induced abnormalities of retinal PKC"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   767   C0035300:Retinal abnormalities [Finding]
   744   C0000768:Abnormalities [Congenital Abnormality]
   744   C0000769:abnormalities [Functional Concept]
   725   C0311448:Abnormal protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   711 E C1704258:Abnormality [Finding]

Phrase: "and"

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "are"

Phrase: "closely"

Phrase: "interrelated"

Phrase: ","

Phrase: "as"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "further by evidence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332120:Evidence [Functional Concept]
   790   C1517331:Further [Spatial Concept]
   756 E C0205108:far [Spatial Concept]

Phrase: "that normalization of PKC activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1882115:Normalization [Research Activity]

Phrase: "in diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "with selective inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "can"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the diabetes-induced increase in free-radical accumulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "(42,"

Phrase: "43"

Phrase: ")."
Processing 00000000.tx.125: The ability of the antioxidant mixture to prevent NO accumulation in diabetes might be due to the fact that nuclear factor Bmediated regulation of the inducible form of NO synthase involves reactive oxygen species (44) or because antioxidants can scavenge NO directly and inhibit formation of cGMP (45). 

Phrase: "The ability of the antioxidant mixture to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0085732:Ability [Organism Attribute]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "NO accumulation in diabetes"

Phrase: "might"

Phrase: "be due to the fact"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0678226:Due to [Functional Concept]
           due
   760   C2987476:Be [Conceptual Entity]
   760   C3146286:Due [Idea or Concept]

Phrase: "that nuclear factor Bmediated regulation of the inducible form of NO synthase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   735   C0851285:Regulation [Governmental or Regulatory Activity]
   735   C1327622:Regulation [Biologic Function]

Phrase: "involves"

Phrase: "reactive oxygen species"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "(44"

Phrase: ")"

Phrase: "or"

Phrase: "because"

Phrase: "antioxidants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003402:Antioxidants [Pharmacologic Substance]

Phrase: "can"

Phrase: "scavenge"

Phrase: "NO directly"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0028128:nitric oxides [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0030015:Oxides [Inorganic Chemical]
   793 E C2986642:oxide [Chemical Viewed Functionally]

Phrase: "and"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "formation of cGMP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C1157595:cGMP formation [Molecular Function]
   790   C0220781:formation [Biologic Function]
   790   C0439634:formation [Spatial Concept]
   790   C1522492:Formation [Functional Concept]

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.126: In summary, long-term administration of antioxidants can inhibit the development of the early stages of diabetic retinopathy. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "long-term administration of antioxidants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0001554:Administration [Occupational Activity]
   760   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "can"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the development of the early stages of diabetic retinopathy."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0243107:development [Physiologic Function]
   742   C0678723:Development [Organism Function]
   742   C1527148:Development [Functional Concept]
   726   C0870411:Developmental stages [Temporal Concept]
Processing 00000000.tx.127: The mechanism by which this action occurs warrants further investigation. 

Phrase: "The mechanism by which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "this action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441472:Action [Functional Concept]
  1000   C3266814:Action [Activity]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "warrants further investigation."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C1261322:Investigation [Health Care Activity]
   827   C1552578:investigation [Idea or Concept]
   755 E C1517586:Investigational [Qualitative Concept]
   755 E C3245491:investigational [Intellectual Product]
Processing 00000000.tx.128: Supplementation with antioxidants represents an achievable and inexpensive adjunct therapy to help inhibit the development of retinopathy in diabetic patients.  

Phrase: "Supplementation with antioxidants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0242297:Supplementation [Therapeutic or Preventive Procedure]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "an achievable"

Phrase: "and"

Phrase: "inexpensive adjunct therapy to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0677850:adjunct therapy [Therapeutic or Preventive Procedure]
   812   C0039798:therapy [Functional Concept]
   812   C0087111:Therapy [Therapeutic or Preventive Procedure]
   812   C1363945:Therapy [Finding]

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the development of retinopathy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]

Phrase: "in diabetic patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.129: ACKNOWLEDGMENTS  This work was funded in part by grants from the American Diabetes Association, Juvenile Diabetes Foundation International, and Thomas Foundation (R.A.K.) and by PHS Grant EY00300 and the Kristin C. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "funded in part"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0016820:funded [Quantitative Concept]
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by grants"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0018173:Grants [Quantitative Concept]
   966 E C1548284:Grant [Idea or Concept]

Phrase: "from the American Diabetes Association,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1705019:American Diabetes Association [Professional Society]
   827   C0004083:Association [Mental Process]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0439849:Association [Qualitative Concept]
   827   C0596070:American [Population Group]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]

Phrase: "Juvenile Diabetes Foundation"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   734   C0011854:Juvenile Diabetes [Disease or Syndrome]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "International,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512888:International [Idea or Concept]

Phrase: "and"

Phrase: "Thomas Foundation"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0016617:Foundation [Organization]
   777 E C0002055:base [Inorganic Chemical]
   777 E C0178499:Base [Chemical Viewed Functionally]
   777 E C1626935:Bases [Quantitative Concept]
   777 E C1880279:Base [Biomedical or Dental Material]
   755 E C0205112:Basal [Spatial Concept]

Phrase: "(R.A.K.)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: "and by PHS Grant EY00300"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0018173:Grant [Quantitative Concept]
   760   C0265220:PHS [Disease or Syndrome]
   760   C1515981:And [Idea or Concept]
   760   C1548284:Grant [Idea or Concept]
   760   C1705397:PHS [Gene or Genome]

Phrase: "and"

Phrase: "the Kristin C."
Processing 00000000.tx.130: Dietrich Diabetes Research Award (T.S.K.). 

Phrase: "Dietrich Diabetes Research Award"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0004446:Award [Manufactured Object]

Phrase: "(T.S.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.131: We appreciate the technical assistance of L. 

Phrase: "We"

Phrase: "appreciate"

Phrase: "the technical assistance of L."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0018896:Assistance [Social Behavior]
   760   C0449851:Technical [Functional Concept]
Processing 00000000.tx.132: Marshall, M. 

Phrase: "Marshall,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551881:Marshall [Population Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.133: Garment, and Dr. 

Phrase: "Garment,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009072:Garment [Manufactured Object]

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.134: C. 

Phrase: "C."
Processing 00000000.tx.135: Miller.  

Phrase: "Miller."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]
Processing 00000000.tx.136: FOOTNOTES  Address correspondence and reprint requests to Renu A. 

Phrase: "FOOTNOTES  Address correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "reprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3273171:Reprint [Intellectual Product]

Phrase: "requests"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0686900:request [Functional Concept]
  1000   C1272683:Request [Functional Concept]
  1000   C1522634:Request [Intellectual Product]

Phrase: "to Renu"

Phrase: "A."
Processing 00000000.tx.137: Kowluru, Kresge Eye Institute, Wayne State University, 4717 St. 

Phrase: "Kowluru,"

Phrase: "Kresge Eye Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021622:institute [Organization]
   827   C1272753:Institute [Idea or Concept]

Phrase: "Wayne State University,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0041740:University [Manufactured Object,Organization]
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]

Phrase: "4717 St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]
Processing 00000000.tx.138: Antoine, Detroit, MI 48201. 

Phrase: "Antoine,"

Phrase: "Detroit,"

Phrase: "MI 48201."
Processing 00000000.tx.139: Received for publication 18 December 2000 and accepted in revised form 8 May 2001. 

Phrase: "Received for publication 18 December 2000"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0034036:Publication [Intellectual Product,Manufactured Object]
   753   C0034037:Publication [Occupational Activity]
   753   C1514756:Received [Qualitative Concept]
   753   C1704324:Publication [Intellectual Product]

Phrase: "and"

Phrase: "accepted in revised form 8 May 2001."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1272684:Accepted [Qualitative Concept]
   748   C1522492:Form [Functional Concept]
   748   C1527075:Revised [Therapeutic or Preventive Procedure]
   748   C1548435:Accepted [Idea or Concept]
   714 E C1548601:Accept [Idea or Concept]
Processing 00000000.tx.140: NO, nitric oxides; 

Phrase: "NO,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0028128:nitric oxides [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:Oxides [Inorganic Chemical]
   827 E C2986642:oxide [Chemical Viewed Functionally]

Phrase: "nitric oxides"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0028128:nitric oxides [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:Oxides [Inorganic Chemical]
   827 E C2986642:oxide [Chemical Viewed Functionally]

Phrase: ";"
Processing 00000000.tx.141: PKC, protein kinase C; 

Phrase: "PKC,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "protein kinase C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.142: TBARS, thiobarbituric acid substances.  

Phrase: "TBARS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0001128:acid substances [Chemical]
   827   C0439861:Substances [Substance]
   734   C0076442:thiobarbituric acid [Organic Chemical]

Phrase: "thiobarbituric acid substances."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0001128:acid substances [Chemical]
   827   C0439861:Substances [Substance]
   734   C0076442:thiobarbituric acid [Organic Chemical]
Processing 00000000.tx.143: REFERENCES TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Engerman RL, Kern TS: Experimental galactosemia produces diabetic-like retinopathy. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Engerman RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "Kern TS"

Phrase: ":"

Phrase: "Experimental galactosemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016952:Galactosaemia [Disease or Syndrome]
   861   C0268151:GALACTOSEMIA [Disease or Syndrome]

Phrase: "produces"

Phrase: "diabetic-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "like retinopathy."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035309:Retinopathy [Disease or Syndrome]
  1000   C1962966:Retinopathy [Finding]
Processing 00000000.tx.144: Diabetes 33:97100, 1984[Abstract] Robison WG Jr, Tillis TN, Laver N, Kinoshita JH: Diabetes-related histopathologies of the rat retina prevented with an aldose reductase inhibitor. 

Phrase: "Diabetes 33"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "97100,"

Phrase: "1984"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Robison WG Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: "Tillis TN,"

Phrase: "Laver N,"

Phrase: "Kinoshita JH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]

Phrase: ":"

Phrase: "Diabetes-related histopathologies of the rat retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0243140:histopathology [Functional Concept]
   714   C0677043:Histopathology [Biomedical Occupation or Discipline]

Phrase: "prevented with an aldose reductase inhibitor."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C2348243:Aldose Reductase Inhibitor [Pharmacologic Substance]
   790   C0002003:Aldose Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1412322:ALDOSE REDUCTASE [Gene or Genome]
   753   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0682934:Aldose [Carbohydrate]
   753   C1999216:Inhibitor [Qualitative Concept]
   719   C0309872:PREVENT [Pharmacologic Substance]
Processing 00000000.tx.145: Exp Eye Res 50:355366, 1990[Medline] Kern TS, Engerman RL: Galactose-induced retinal microangiopathy in rats. 

Phrase: "Exp Eye Res 50"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   812   C0015392:Eye [Body Part, Organ, or Organ Component]
   812   C1280202:Eye [Body Part, Organ, or Organ Component]
   812   C1417055:EXP [Gene or Genome]
   812   C2347379:RES [Finding]
   756 E C0029144:optic [Occupation or Discipline]
   756 E C0042789:Ocular [Organism Function]
   756 E C1299003:Ocular [Spatial Concept]
   719 E C0014236:Ophthalmia [Disease or Syndrome]
   719 E C0700042:Oculus [Body Location or Region]

Phrase: ":"

Phrase: "355366,"

Phrase: "1990"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kern TS,"

Phrase: "Engerman RL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: ":"

Phrase: "Galactose-induced retinal microangiopathy in rats."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0155765:Microangiopathy [Disease or Syndrome]
Processing 00000000.tx.146: Invest Ophthalmol Vis Sci 36:490496, 1995[Abstract] Kern TS, Engerman RL: A mouse model of diabetic retinopathy. 

Phrase: "Invest"

Phrase: "Ophthalmol Vis Sci 36"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1571809:VIS [Therapeutic or Preventive Procedure]
   812   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "490496,"

Phrase: "1995"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kern TS,"

Phrase: "Engerman RL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: ":"

Phrase: "A mouse model of diabetic retinopathy."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C2986594:Mouse Model [Experimental Model of Disease]
   753   C3161035:Model [Intellectual Product]
Processing 00000000.tx.147: Arch Ophthalmol 114:986990, 1996[Abstract] Stitt AW, Li YM, Gardiner TA, Bucala R, Archer DB, Vlassara H: Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. 

Phrase: "Arch Ophthalmol 114"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0230467:arch [Body Location or Region]
   827   C0741204:ARCH [Body Space or Junction]

Phrase: ":"

Phrase: "986990,"

Phrase: "1996"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Stitt AW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282379:AW [Geographic Area]
   861   C0332281:AW [Qualitative Concept]

Phrase: "Li YM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2349168:ym [Quantitative Concept]

Phrase: "Gardiner TA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: "Bucala R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Archer DB,"

Phrase: "Vlassara H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ":"

Phrase: "Advanced glycation end products (AGEs)"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
   812   C0205179:Advanced [Qualitative Concept]
   812   C0444930:End [Spatial Concept]
   812   C0598528:glycation [Phenomenon or Process]
   812   C1514468:Products [Entity]
   812   C2746065:End [Temporal Concept]
   779 E C0725066:Advance [Medical Device]
   779 E C1704444:Product [Quantitative Concept]
   756 E C0205088:Terminal [Temporal Concept]
   756 E C1705314:Terminal [Manufactured Object]
   756 E C1705315:Terminal [Spatial Concept]

Phrase: "co-localize with AGE receptors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0101725:AGE receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C0001779:Age [Organism Attribute]
   760   C0392752:localize [Spatial Concept]
   760   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "in the retinal vasculature"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005839:vasculature [Body Part, Organ, or Organ Component]

Phrase: "of diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "and of AGE-infused rats."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0001779:Age [Organism Attribute]
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C1515981:And [Idea or Concept]
Processing 00000000.tx.148: Am J Pathol 150:523531, 1997[Abstract] Xia P, Inoguchi T, Kern TS, Engerman RL, Oates PJ, King GL: Characterization of the mechanism for the chronic activation of DAG-PKC pathway in diabetes and hypergalactosemia. 

Phrase: "Am"

Phrase: "J Pathol 150"

Phrase: ":"

Phrase: "523531,"

Phrase: "1997"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Xia P,"

Phrase: "Inoguchi T,"

Phrase: "Kern TS,"

Phrase: "Engerman RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "Oates PJ,"

Phrase: "King"

Phrase: "GL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0018229:GL [Geographic Area]
  1000   C1423073:GL [Gene or Genome]
  1000   C1427674:GL [Gene or Genome]

Phrase: ":"

Phrase: "Characterization of the mechanism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880022:Characterization [Activity]

Phrase: "for the chronic activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "of DAG-PKC pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1704259:Pathway [Molecular Function]
   804   C1705987:Pathway [Conceptual Entity]
   717   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "hypergalactosemia."
Processing 00000000.tx.149: Diabetes 43:11221129, 1994[Abstract] Kowluru RA, Jirousek MR, Stramm LE, Farid NA, Engerman RL, Kern TS: Abnormalities of retinal metabolism in diabetes or experimental galactosemia. 

Phrase: "Diabetes 43"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "11221129,"

Phrase: "1994"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kowluru RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Jirousek MR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347167:Mr. [Conceptual Entity]

Phrase: "Stramm LE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439090:LE [Idea or Concept]
   861   C1423767:LE [Gene or Genome]

Phrase: "Farid NA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1272460:{NA} [Qualitative Concept]

Phrase: "Engerman RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "Kern TS"

Phrase: ":"

Phrase: "Abnormalities of retinal metabolism"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   819   C0035300:Retinal abnormalities [Finding]
   770   C0000768:Abnormalities [Congenital Abnormality]
   770   C0000769:abnormalities [Functional Concept]
   737 E C1704258:Abnormality [Finding]

Phrase: "in diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "or"

Phrase: "experimental galactosemia."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016952:Galactosaemia [Disease or Syndrome]
   861   C0268151:GALACTOSEMIA [Disease or Syndrome]
Processing 00000000.tx.150: V. 

Phrase: "V."
Processing 00000000.tx.151: Relationship between protein kinase C and ATPases. 

Phrase: "Relationship between protein kinase C"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "ATPases."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001473:ATPases [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C1706373:ATPase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.152: Diabetes 47:464469, 1998[Abstract] Armstrong D, Abdella N, Salman A, Miller N, Rahman EA, Bojancyzk M: Relationship of lipid peroxides to diabetic complications. 

Phrase: "Diabetes 47"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "464469,"

Phrase: "1998"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Armstrong D,"

Phrase: "Abdella N,"

Phrase: "Salman A,"

Phrase: "Miller N,"

Phrase: "Rahman EA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]

Phrase: "Bojancyzk M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Relationship of lipid peroxides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439849:Relationship [Qualitative Concept]
   770   C1705630:Relationship [Idea or Concept]
   770   C1706279:Relationship [Idea or Concept]
   770   C3540605:Relationship [Intellectual Product]

Phrase: "to diabetic complications."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0342257:Diabetic Complications [Pathologic Function]
   861   C0009566:Complications [Pathologic Function]
   861   C1171258:complications [Pathologic Function]
   827 E C2362589:Complication [Idea or Concept]
   777 E C0231242:Complicated [Functional Concept]
Processing 00000000.tx.153: J Diabetes Complications 6:116122, 1992[Medline] Kowluru RA, Kern TS, Engerman RL, Armstrong D: Abnormalities of retinal metabolism in diabetes or experimental galactosemia. 

Phrase: "J Diabetes Complications 6"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0342257:Diabetes Complications [Pathologic Function]
   812   C0009566:Complications [Pathologic Function]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]
   812   C1171258:complications [Pathologic Function]
   779 E C2362589:Complication [Idea or Concept]
   729 E C0231242:Complicated [Functional Concept]

Phrase: ":"

Phrase: "116122,"

Phrase: "1992"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kowluru RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Kern TS,"

Phrase: "Engerman RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "Armstrong D"

Phrase: ":"

Phrase: "Abnormalities of retinal metabolism"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   819   C0035300:Retinal abnormalities [Finding]
   770   C0000768:Abnormalities [Congenital Abnormality]
   770   C0000769:abnormalities [Functional Concept]
   737 E C1704258:Abnormality [Finding]

Phrase: "in diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "or"

Phrase: "experimental galactosemia."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016952:Galactosaemia [Disease or Syndrome]
   861   C0268151:GALACTOSEMIA [Disease or Syndrome]
Processing 00000000.tx.154: III. 

Phrase: "III."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]
Processing 00000000.tx.155: Effects of antioxidants. 

Phrase: "Effects of antioxidants."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   841   C3179302:Antioxidant Effects [Physiologic Function]
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.156: Diabetes 45:12331237, 1996[Abstract] Kador PF, Akagi Y, Takahashi Y, Ikebe H, Wyman M, Kinoshita JH: Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors. 

Phrase: "Diabetes 45"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "12331237,"

Phrase: "1996"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kador PF,"

Phrase: "Akagi Y,"

Phrase: "Takahashi Y,"

Phrase: "Ikebe H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Wyman M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kinoshita JH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]

Phrase: ":"

Phrase: "Prevention of retinal vessel changes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0199176:Prevention [Therapeutic or Preventive Procedure]
   760   C1706420:PREVENTION [Research Activity]
   760   C2700409:prevention [Qualitative Concept]

Phrase: "associated with diabetic retinopathy"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0011884:Diabetic Retinopathy [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0035309:Retinopathy [Disease or Syndrome]
   770   C0241863:DIABETIC [Finding]
   770   C1962966:Retinopathy [Finding]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in galactose-fed dogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0012984:Dogs [Mammal]
   827   C1280551:Dogs [Mammal]

Phrase: "by aldose reductase inhibitors."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   966   C2348243:Aldose Reductase Inhibitor [Pharmacologic Substance]
   901   C0002003:Aldose Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1412322:ALDOSE REDUCTASE [Gene or Genome]
   827   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   827   C0682934:Aldose [Carbohydrate]
   793 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.157: Arch Ophthalmol 108:13011309, 1990[Abstract] Aiello LP, Pu X, Zhen ZY, Park DJ, Newsome WP, King GL: Vascular endothelial growth factor (VEGF) activation of phospholipase C-gamma, P13-kinase & PKC pathways and their effects on endothelial cell proliferation. 

Phrase: "Arch Ophthalmol 108"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0230467:arch [Body Location or Region]
   827   C0741204:ARCH [Body Space or Junction]

Phrase: ":"

Phrase: "13011309,"

Phrase: "1990"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Aiello LP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037943:LP [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C0228341:LP [Body Part, Organ, or Organ Component]
   861   C2239920:LP [Gene or Genome]

Phrase: "Pu X,"

Phrase: "Zhen ZY,"

Phrase: "Park DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Newsome WP,"

Phrase: "King"

Phrase: "GL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0018229:GL [Geographic Area]
  1000   C1423073:GL [Gene or Genome]
  1000   C1427674:GL [Gene or Genome]

Phrase: ":"

Phrase: "Vascular endothelial growth factor (VEGF) activation of phospholipase C-gamma,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   784   C1155436:phospholipase C activation [Molecular Function]
   784   C2249824:activation of growth [Organism Function]
   742   C1879547:Activation [Activity]

Phrase: "P13-kinase & PKC pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1704259:Pathways [Molecular Function]
   799   C1705987:Pathways [Conceptual Entity]

Phrase: "and"

Phrase: "their effects on endothelial cell proliferation."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.158: Invest Ophthalmol Vis Sci 37:S204, 1996 Baynes JW: Role of oxidative stress in development of complications in diabetes. 

Phrase: "Invest"

Phrase: "Ophthalmol Vis Sci 37"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1571809:VIS [Therapeutic or Preventive Procedure]
   812   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "S204,"

Phrase: "1996 Baynes JW"

Phrase: ":"

Phrase: "Role of oxidative stress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of complications"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0009566:Complications [Pathologic Function]
  1000   C1171258:complications [Pathologic Function]
   966 E C2362589:Complication [Idea or Concept]
   916 E C0231242:Complicated [Functional Concept]

Phrase: "in diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.159: Diabetes 40:405412, 1991[Abstract] Kowluru RA, Kern TS, Engerman RL: Abnormalities of retinal metabolism in diabetes or experimental galactosemia. 

Phrase: "Diabetes 40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]
   861   C0439509:/40 [Temporal Concept]

Phrase: ":"

Phrase: "405412,"

Phrase: "1991"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kowluru RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Kern TS,"

Phrase: "Engerman RL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: ":"

Phrase: "Abnormalities of retinal metabolism"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   819   C0035300:Retinal abnormalities [Finding]
   770   C0000768:Abnormalities [Congenital Abnormality]
   770   C0000769:abnormalities [Functional Concept]
   737 E C1704258:Abnormality [Finding]

Phrase: "in diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "or"

Phrase: "experimental galactosemia."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016952:Galactosaemia [Disease or Syndrome]
   861   C0268151:GALACTOSEMIA [Disease or Syndrome]
Processing 00000000.tx.160: IV. 

Phrase: "IV."
Processing 00000000.tx.161: Antioxidant defense system. 

Phrase: "Antioxidant defense system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.162: Free Radic Biol Med 22:587592, 1997[Medline] Kowluru RA, Engerman RL, Kern TS: Diabetes-induced metabolic abnormalities in myocardium: effect of antioxidant therapy. 

Phrase: "Free Radic Biol Med 22"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0332296:free [Functional Concept]
   804   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
   804   C1880497:Free [Qualitative Concept]
   804   C1996904:Free [Qualitative Concept]

Phrase: ":"

Phrase: "587592,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kowluru RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Engerman RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "Kern TS"

Phrase: ":"

Phrase: "Diabetes-induced metabolic abnormalities in myocardium"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0000768:Abnormalities [Congenital Abnormality]
   753   C0000769:abnormalities [Functional Concept]
   719 E C1704258:Abnormality [Finding]

Phrase: ":"

Phrase: "effect of antioxidant therapy."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1518681:Therapy Effect [Finding]
   819   C3179302:Anti-Oxidant Effect [Physiologic Function]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.163: Free Radic Res 32:6774, 2000[Medline] Grant MB, Ellis EA, Wachowski MB, Murray FT: Free radical derived oxidant localization in retinas of BBZ/WOR diabetic rats (Abstract). 

Phrase: "Free Radic Res 32"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0332296:free [Functional Concept]
   812   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
   812   C1880497:Free [Qualitative Concept]
   812   C1996904:Free [Qualitative Concept]
   812   C2347379:RES [Finding]

Phrase: ":"

Phrase: "6774,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Grant MB,"

Phrase: "Ellis EA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]

Phrase: "Wachowski MB,"

Phrase: "Murray FT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1881534:ft. [Functional Concept]

Phrase: ":"

Phrase: "Free radical derived oxidant localization in retinas of BBZ/WOR diabetic rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0475264:Localisation [Functional Concept]
   736   C1744691:localisation [Biologic Function]

Phrase: "(Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.164: Diabetes 45 (Suppl. 2):192, 1996 Kowluru R, Kern TS, Engerman RL: Abnormalities of retinal metabolism in diabetes or galactosemia II. 

Phrase: "Diabetes 45"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(Suppl. 2"

Phrase: ")"

Phrase: ":"

Phrase: "192,"

Phrase: "1996 Kowluru R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "Kern TS,"

Phrase: "Engerman RL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: ":"

Phrase: "Abnormalities of retinal metabolism"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   819   C0035300:Retinal abnormalities [Finding]
   770   C0000768:Abnormalities [Congenital Abnormality]
   770   C0000769:abnormalities [Functional Concept]
   737 E C1704258:Abnormality [Finding]

Phrase: "in diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "or"

Phrase: "galactosemia II."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0268155:Galactosaemia II [Disease or Syndrome]
Processing 00000000.tx.165: Comparison of gamma-glutamyl transpeptidase in retina and cerebral cortex, and effects of antioxidant therapy. 

Phrase: "Comparison of gamma-glutamyl transpeptidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Comparison [Activity]

Phrase: "in retina"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035298:Retina [Body Part, Organ, or Organ Component]
  1000   C1278894:Retina [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "cerebral cortex,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "effects of antioxidant therapy."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   819   C3179302:Anti-Oxidant Effects [Physiologic Function]
   802   C1518681:Therapy Effect [Finding]
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.166: Curr Eye Res 13:891896, 1994[Medline] Mayer-Davis EJ, Bell RA, Reboussin BA, Rushing J, Marshall JA, Hamman RF: Antioxidant nutrient intake and diabetic retinopathy: the San Luis Valley Diabetes Study. 

Phrase: "Curr Eye Res 13"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   812   C0015392:Eye [Body Part, Organ, or Organ Component]
   812   C1280202:Eye [Body Part, Organ, or Organ Component]
   812   C2347379:RES [Finding]
   756 E C0029144:optic [Occupation or Discipline]
   756 E C0042789:Ocular [Organism Function]
   756 E C1299003:Ocular [Spatial Concept]
   719 E C0014236:Ophthalmia [Disease or Syndrome]
   719 E C0700042:Oculus [Body Location or Region]

Phrase: ":"

Phrase: "891896,"

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mayer-Davis EJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1718783:Ej [Immunologic Factor]

Phrase: "Bell RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Reboussin BA,"

Phrase: "Rushing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443052:rushing [Qualitative Concept]

Phrase: "J,"

Phrase: "Marshall JA,"

Phrase: "Hamman RF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035448:RF [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0201660:RF [Laboratory Procedure]
   861   C0748398:RF [Finding]

Phrase: ":"

Phrase: "Antioxidant nutrient intake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0006777:Nutrient intake [Quantitative Concept]
   827   C1512806:Intake [Functional Concept]

Phrase: "and"

Phrase: "diabetic retinopathy"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0011884:Diabetic Retinopathy [Disease or Syndrome]
   861   C0035309:Retinopathy [Disease or Syndrome]
   861   C0241863:DIABETIC [Finding]
   861   C1962966:Retinopathy [Finding]

Phrase: ":"

Phrase: "the San Luis Valley Diabetes Study."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0011849:Diabetes [Disease or Syndrome]
   804   C0557651:Study [Manufactured Object]
   804   C2603343:Study [Research Activity]
Processing 00000000.tx.167: Ophthalmology 105:22642270, 1998[Medline] Hammes HP, Bartmann A, Engel L, Wulfroth P: Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine. 

Phrase: "Ophthalmology 105"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0029087:Ophthalmology [Biomedical Occupation or Discipline]
   861   C1555792:Ophthalmology [Professional or Occupational Group]
   789 E C0205481:Ophthalmologic [Functional Concept]

Phrase: ":"

Phrase: "22642270,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hammes HP,"

Phrase: "Bartmann A,"

Phrase: "Engel L,"

Phrase: "Wulfroth P"

Phrase: ":"

Phrase: "Antioxidant treatment of experimental diabetic retinopathy"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "in rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "with nicanartine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0391211:nicanartine [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.168: Diabetologia 40:629634, 1997[Medline] Ansari NH, Zhang W, Fulep E, Mansour A: Prevention of pericyte loss by Trolox in diabetic rat retina. 

Phrase: "Diabetologia 40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ":"

Phrase: "629634,"

Phrase: "1997"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ansari NH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0268059:NH [Disease or Syndrome]

Phrase: "Zhang W,"

Phrase: "Fulep E,"

Phrase: "Mansour A"

Phrase: ":"

Phrase: "Prevention of pericyte loss"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0199176:Prevention [Therapeutic or Preventive Procedure]
   770   C1706420:PREVENTION [Research Activity]
   770   C2700409:prevention [Qualitative Concept]

Phrase: "by Trolox"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0147003:Trolox [Organic Chemical,Pharmacologic Substance]

Phrase: "in diabetic rat retina."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035298:Retina [Body Part, Organ, or Organ Component]
   827   C1278894:Retina [Body Part, Organ, or Organ Component]
Processing 00000000.tx.169: J Toxicol Environ Health 24:467475, 1998 Kowluru RA, Engerman RL, Kern TS: Abnormalities of retinal metabolism in diabetes or experimental galactosemia VI. 

Phrase: "J Toxicol"

Phrase: "Environ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1568941:Environ [Organic Chemical]

Phrase: "Health 24"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0018684:Health [Idea or Concept]
   761 E C0031206:healthiness [Finding]

Phrase: ":"

Phrase: "467475,"

Phrase: "1998 Kowluru RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3538806:Ra [Spatial Concept]

Phrase: "Engerman RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "Kern TS"

Phrase: ":"

Phrase: "Abnormalities of retinal metabolism"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   819   C0035300:Retinal abnormalities [Finding]
   770   C0000768:Abnormalities [Congenital Abnormality]
   770   C0000769:abnormalities [Functional Concept]
   737 E C1704258:Abnormality [Finding]

Phrase: "in diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "or"

Phrase: "experimental galactosemia VI."
Processing 00000000.tx.170: Comparison of retinal and cerebral cortex metabolism, and effects of antioxidant therapy. 

Phrase: "Comparison of retinal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "cerebral cortex metabolism,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]
   734   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "effects of antioxidant therapy."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   819   C3179302:Anti-Oxidant Effects [Physiologic Function]
   802   C1518681:Therapy Effect [Finding]
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.171: Free Radic Biol Med 26:371378, 1999[Medline] Ishii H, Koya D, King GL: Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus. 

Phrase: "Free Radic Biol Med 26"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0332296:free [Functional Concept]
   804   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
   804   C1880497:Free [Qualitative Concept]
   804   C1996904:Free [Qualitative Concept]

Phrase: ":"

Phrase: "371378,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ishii H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Koya D,"

Phrase: "King"

Phrase: "GL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0018229:GL [Geographic Area]
  1000   C1423073:GL [Gene or Genome]
  1000   C1427674:GL [Gene or Genome]

Phrase: ":"

Phrase: "Protein kinase C activation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C3546691:protein kinase C activation [Molecular Function]
   923   C1819041:protein kinase activation [Cell Function]
   902   C0599177:protein activation [Genetic Function]
   812   C1879547:Activation [Activity]
   756   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   708   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   708   C1168438:Protein C [Laboratory Procedure]
   708   C1418943:PROTEIN C [Gene or Genome]
   708   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "its role in the development of vascular complications"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "in diabetes mellitus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]
Processing 00000000.tx.172: J Mol Med 76:2131, 1998[Medline] Kowluru RA, Engerman RL, Case GL, Kern TS: Retinal glutamate in diabetes and effect of antioxidants. 

Phrase: "J Mol Med 76"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C2346604:J/mol [Quantitative Concept]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "2131,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kowluru RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Engerman RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "Case GL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0018229:GL [Geographic Area]
   861   C1423073:GL [Gene or Genome]
   861   C1427674:GL [Gene or Genome]

Phrase: "Kern TS"

Phrase: ":"

Phrase: "Retinal glutamate in diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   770   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "effect of antioxidants."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   841   C3179302:Antioxidant Effect [Physiologic Function]
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.173: Neurochem Int 38:385391, 2001[Medline] Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein. 

Phrase: "Neurochem Int 38"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0063789:INT [Organic Chemical]
   827   C3272375:INT [Intellectual Product]

Phrase: ":"

Phrase: "385391,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bradford MM"

Phrase: ":"

Phrase: "A rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]

Phrase: "and"

Phrase: "sensitive method for the quantitation of microgram quantities of protein."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   741   C1547724:Quantity method [Idea or Concept]
   739   C0025663:Method [Intellectual Product]
   739   C0449851:Method [Functional Concept]
   739   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.174: Anal Biochem 72:248258, 1974 Engerman RL, Kern TS: Retinopathy in animal models of diabetes. 

Phrase: "Anal Biochem 72"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003461:Anal [Body Part, Organ, or Organ Component]
   827   C2939124:Anal [Spatial Concept]

Phrase: ":"

Phrase: "248258,"

Phrase: "1974 Engerman RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1419337:RL [Gene or Genome]
   827   C3539667:RL [Gene or Genome]

Phrase: "Kern TS"

Phrase: ":"

Phrase: "Retinopathy in animal models of diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035309:Retinopathy [Disease or Syndrome]
   753   C1962966:Retinopathy [Finding]
Processing 00000000.tx.175: Diabetes Metab Rev 11:109120, 1995[Medline] Kern TS, Tang J, Mizutani M, Kowluru RA, Nagraj RH, Romeo G, Podesta F, Lorenzi M: Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. 

Phrase: "Diabetes Metab Rev 11"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0011849:Diabetes [Disease or Syndrome]
   812   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "109120,"

Phrase: "1995"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kern TS,"

Phrase: "Tang J,"

Phrase: "Mizutani M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kowluru RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Nagraj RH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: "Romeo G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Podesta F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Lorenzi M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Response of capillary cell death"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0871261:Response [Organism Attribute]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]

Phrase: "to aminoguanidine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282774:aminoguanidine [Organic Chemical,Pharmacologic Substance]

Phrase: "predicts"

Phrase: "the development of retinopathy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]

Phrase: ":"

Phrase: "comparison of diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "galactosemia."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016952:Galactosaemia [Disease or Syndrome]
  1000   C0268151:GALACTOSEMIA [Disease or Syndrome]
Processing 00000000.tx.176: Invest Ophthalmol Vis Sci 41:39723978, 2000[Abstract/Free FullText] Siperstein M, Under R, Madison L: Studies of muscle capillary basement membrane in normal subjects, diabetic, and prediabetic patients. 

Phrase: "Invest"

Phrase: "Ophthalmol Vis Sci 41"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1571809:VIS [Therapeutic or Preventive Procedure]
   812   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "39723978,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Siperstein M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Under R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Madison L"

Phrase: ":"

Phrase: "Studies of muscle capillary basement membrane"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0947630:studies [Laboratory Procedure]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]

Phrase: "in normal subjects,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0205307:Normal [Qualitative Concept]
   861   C0439166:% normal [Quantitative Concept]
   861   C2347086:% Normal [Quantitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "diabetic,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "prediabetic patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.177: J Clin Invest 47:19731999, 1968[Medline] Tesfamariam B, Cohen RA: Free radicals mediate endothelial dysfunction caused by elevated glucose. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "47"

Phrase: ":"

Phrase: "19731999,"

Phrase: "1968"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tesfamariam B,"

Phrase: "Cohen RA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: ":"

Phrase: "Free radicals"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0016693:Free Radicals [Biologically Active Substance,Chemical Viewed Structurally]
   861   C0302912:radicals [Chemical Viewed Structurally]
   861   C0332296:free [Functional Concept]
   861   C1880497:Free [Qualitative Concept]
   861   C1996904:Free [Qualitative Concept]
   827 E C0439807:Radical [Qualitative Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "endothelial dysfunction"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0856169:endothelial dysfunction [Disease or Syndrome]
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "caused by elevated glucose."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0205250:Elevated [Qualitative Concept]
   770   C3163633:Elevated [Qualitative Concept]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.178: Am J Physiol 263:H321H326, 1992[Abstract/Free FullText] Kern TS, Kowluru R, Engerman RL: Abnormalities of retinal metabolism in diabetes or galactosemia: ATPases and glutathione. 

Phrase: "Am"

Phrase: "J Physiol 263"

Phrase: ":"

Phrase: "H321H326,"

Phrase: "1992"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kern TS,"

Phrase: "Kowluru R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Engerman RL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: ":"

Phrase: "Abnormalities of retinal metabolism"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   819   C0035300:Retinal abnormalities [Finding]
   770   C0000768:Abnormalities [Congenital Abnormality]
   770   C0000769:abnormalities [Functional Concept]
   737 E C1704258:Abnormality [Finding]

Phrase: "in diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "or"

Phrase: "galactosemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016952:Galactosaemia [Disease or Syndrome]
  1000   C0268151:GALACTOSEMIA [Disease or Syndrome]

Phrase: ":"

Phrase: "ATPases"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001473:ATPases [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C1706373:ATPase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "glutathione."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.179: Invest Ophthalmol Vis Sci 35:29622967, 1994[Abstract] Wohaieb SA, Godin DV: Alterations in free radical tissue-defense mechanisms in streptozotocin-induced diabetes. 

Phrase: "Invest"

Phrase: "Ophthalmol Vis Sci 35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1571809:VIS [Therapeutic or Preventive Procedure]
   812   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "29622967,"

Phrase: "1994"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Wohaieb SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Godin DV"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0279354:DV [Therapeutic or Preventive Procedure]
   861   C1704645:DV [Conceptual Entity]

Phrase: ":"

Phrase: "Alterations in free radical tissue-defense mechanisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   788   C1517311:Free Radical Alteration [Molecular Function]
   714   C1515926:Alteration [Idea or Concept]

Phrase: "in streptozotocin-induced diabetes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0038433:Streptozotocin Diabetes [Experimental Model of Disease]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.180: Diabetes 36:10141018, 1987[Abstract] Ellis EA, Grant MB, Murray FT, Guberski DL, Kubilis PS, Lutty GA: Increased NADH oxidase activity in the retina of BBZ/W or diabetic rat. 

Phrase: "Diabetes 36"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "10141018,"

Phrase: "1987"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ellis EA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]

Phrase: "Grant MB,"

Phrase: "Murray FT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1881534:ft. [Functional Concept]

Phrase: "Guberski DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "Kubilis PS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "Lutty GA"

Phrase: ":"

Phrase: "Increased NADH oxidase activity in the retina of BBZ/W"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0131722:NADH oxidase [Amino Acid, Peptide, or Protein,Enzyme]
   757   C0474395:increased activity [Finding]
   753   C1324492:retinal oxidase activity [Molecular Function]
   739   C0027289:NADH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   739   C0205177:Activity [Functional Concept]
   739   C0242417:Oxidase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1561536:*Activity [Idea or Concept]
   722   C1295247:Retinal oxidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "diabetic rat."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
   861   C0241863:DIABETIC [Finding]
Processing 00000000.tx.181: Free Radic Biol Med 24:111120, 1998[Medline] Li W, Yanoff M, Jian B, He Z: Altered mRNA levels of antioxidant enzymes in pre-apoptotic pericytes from human diabetic retinas. 

Phrase: "Free Radic Biol Med 24"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0332296:free [Functional Concept]
   804   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
   804   C1880497:Free [Qualitative Concept]
   804   C1996904:Free [Qualitative Concept]

Phrase: ":"

Phrase: "111120,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Li W,"

Phrase: "Yanoff M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Jian B,"

Phrase: "He Z"

Phrase: ":"

Phrase: "Altered mRNA levels of antioxidant enzymes"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   783   C0014440:enzymes levels [Laboratory Procedure]
   783   C1287349:enzymes levels [Laboratory or Test Result]
   753   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in pre-apoptotic pericytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0598800:Pericytes [Cell]

Phrase: "from human diabetic retinas."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0035298:Retinas [Body Part, Organ, or Organ Component]
   793 E C1278894:Retina [Body Part, Organ, or Organ Component]
Processing 00000000.tx.182: Cell Mol Biol 45:5966, 1999 Knudsen CA, Tappel AL, North JA: Multiple antioxidants protect against heme protein and lipid oxidation in kidney tissue. 

Phrase: "Cell Mol Biol 45"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0007634:Cell [Cell]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1456781:mole [Neoplastic Process]
   812   C1704653:Cell [Medical Device]
   812   C1824986:mol [Gene or Genome]
   812   C1948049:Cell [Spatial Concept]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "5966,"

Phrase: "1999 Knudsen CA,"

Phrase: "Tappel AL,"

Phrase: "North JA"

Phrase: ":"

Phrase: "Multiple antioxidants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003402:Antioxidants [Pharmacologic Substance]

Phrase: "protect against heme protein"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0018974:Heme Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783 E C0005832:blood protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0018966:Haem [Biologically Active Substance,Organic Chemical]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "lipid oxidation in kidney tissue."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C2612546:lipid oxidation [Molecular Function]
   760   C0023779:Lipid [Lipid]
   760   C0030011:Oxidation [Molecular Function]
Processing 00000000.tx.183: Free Radic Biol Med 20:165173, 1996[Medline] Pryor WA: Vitamin E and heart disease: basic science to clinical intervention trials. 

Phrase: "Free Radic Biol Med 20"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0332296:free [Functional Concept]
   804   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
   804   C1880497:Free [Qualitative Concept]
   804   C1996904:Free [Qualitative Concept]

Phrase: ":"

Phrase: "165173,"

Phrase: "1996"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pryor WA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043038:WA [Geographic Area]

Phrase: ":"

Phrase: "Vitamin E"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042874:Vitamin E [Lipid,Pharmacologic Substance,Vitamin]
   944 E C0591450:Ephynal [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "and"

Phrase: "heart disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0018799:Heart disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   861   C0018787:Heart [Body Part, Organ, or Organ Component]
   861   C1281570:Heart [Body Part, Organ, or Organ Component]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "basic science to clinical intervention trials."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0681833:Basic Science [Research Activity]
   753   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.184: Free Radic Biol Med 28:141164, 2000[Medline] Brownlee M, Vlassara H, Kooney A, Ulrich P, Cerami A: Aminoguanidine prevents diabetes-induced arterial wall protein cross linking. 

Phrase: "Free Radic Biol Med 28"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0332296:free [Functional Concept]
   804   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
   804   C1880497:Free [Qualitative Concept]
   804   C1996904:Free [Qualitative Concept]

Phrase: ":"

Phrase: "141164,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Brownlee M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Vlassara H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kooney A,"

Phrase: "Ulrich P,"

Phrase: "Cerami A"

Phrase: ":"

Phrase: "Aminoguanidine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282774:aminoguanidine [Organic Chemical,Pharmacologic Substance]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "diabetes-induced arterial wall protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "cross linking."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]
Processing 00000000.tx.185: Science 232:16291632, 1986[Medline] Picard S, Parthasarathy S, Fruebis J, Wiztum JL: Aminoguanidine inhibits oxidative modification of low-density lipoprotein and the subsequent increase in uptake by macrophage scavenger receptors. 

Phrase: "Science 232"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "16291632,"

Phrase: "1986"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Picard S,"

Phrase: "Parthasarathy S,"

Phrase: "Fruebis J,"

Phrase: "Wiztum JL"

Phrase: ":"

Phrase: "Aminoguanidine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282774:aminoguanidine [Organic Chemical,Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "oxidative modification of low-density lipoprotein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1158918:lipoprotein modification [Molecular Function]
   753   C0392747:Modification [Functional Concept]
   753   C1554963:modification [Qualitative Concept]

Phrase: "and"

Phrase: "the subsequent increase in uptake"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "by macrophage scavenger receptors."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0212576:Scavenger Receptors, Macrophage [Amino Acid, Peptide, or Protein,Receptor]
   966 E C1417374:MACROPHAGE SCAVENGER RECEPTOR [Gene or Genome]
   901   C0074129:Receptors, Scavenger [Amino Acid, Peptide, or Protein,Receptor]
   827   C0017108:scavenger [Medical Device]
   827   C0024432:macrophage [Cell]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   827   C1003377:scavenger [Fish]
Processing 00000000.tx.186: Proc Natl Acad Sci U S A 89:68766880, 1992[Abstract] Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TP, Moore WM, Currie MG, Corbett JA, McDaniel ML: Prevention of diabetic vascular dysfunction by guanidines: inhibition of nitric oxide synthase versus advanced glycation end-product formation. 

Phrase: "Proc Natl Acad Sci U S A 89"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   835   C0041703:U.S.A. [Geographic Area]
           U S
   793   C0268596:ACAD [Disease or Syndrome]
   793   C1418943:PROC [Gene or Genome]
   793   C2700624:ACAD [Cell Function]
   793   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "68766880,"

Phrase: "1992"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Tilton RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Chang K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Hasan KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Smith SR,"

Phrase: "Petrash JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Misko TP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541334:TP [Gene or Genome]

Phrase: "Moore WM,"

Phrase: "Currie MG,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "Corbett JA,"

Phrase: "McDaniel ML"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: ":"

Phrase: "Prevention of diabetic vascular dysfunction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0199176:Prevention [Therapeutic or Preventive Procedure]
   760   C1706420:PREVENTION [Research Activity]
   760   C2700409:prevention [Qualitative Concept]

Phrase: "by guanidines"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0018320:Guanidines [Organic Chemical]
   966 E C0120446:Guanidine [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "inhibition of nitric oxide synthase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "versus"

Phrase: "advanced glycation end-product formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0220781:formation [Biologic Function]
   804   C0439634:formation [Spatial Concept]
   804   C1522492:Formation [Functional Concept]
Processing 00000000.tx.187: Diabetes 42:221232, 1993[Abstract] Kowluru RA, Engerman EL, Kern TS: Abnormalities of retinal metabolism in diabetes or experimental galactosemia VIII. 

Phrase: "Diabetes 42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "221232,"

Phrase: "1993"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kowluru RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Engerman EL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416870:EL [Gene or Genome]
   861   C1823249:EL [Gene or Genome]

Phrase: "Kern TS"

Phrase: ":"

Phrase: "Abnormalities of retinal metabolism"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   819   C0035300:Retinal abnormalities [Finding]
   770   C0000768:Abnormalities [Congenital Abnormality]
   770   C0000769:abnormalities [Functional Concept]
   737 E C1704258:Abnormality [Finding]

Phrase: "in diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "or"

Phrase: "experimental galactosemia VIII."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0445599:VIII [Intellectual Product]
   827   C1413661:VIII [Gene or Genome]
Processing 00000000.tx.188: Prevention by aminoguanidine. 

Phrase: "Prevention by aminoguanidine."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0199176:Prevention [Therapeutic or Preventive Procedure]
   790   C1706420:PREVENTION [Research Activity]
   790   C2700409:prevention [Qualitative Concept]
Processing 00000000.tx.189: Curr Eye Res 21:814819, 2000[Medline] Cotter MA, Love A, Watt MJ, Cameron ME, Dines KC: Effects of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats. 

Phrase: "Curr Eye Res 21"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   812   C0015392:Eye [Body Part, Organ, or Organ Component]
   812   C1280202:Eye [Body Part, Organ, or Organ Component]
   812   C2347379:RES [Finding]
   756 E C0029144:optic [Occupation or Discipline]
   756 E C0042789:Ocular [Organism Function]
   756 E C1299003:Ocular [Spatial Concept]
   719 E C0014236:Ophthalmia [Disease or Syndrome]
   719 E C0700042:Oculus [Body Location or Region]

Phrase: ":"

Phrase: "814819,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cotter MA,"

Phrase: "Love A,"

Phrase: "Watt MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Cameron"

Phrase: "ME,"

Phrase: "Dines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0337879:Dine [Population Group]
  1000   C0574545:Dine [Language]

Phrase: "KC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022575:kc [Disease or Syndrome]
  1000   C1705783:KC [Gene or Genome]

Phrase: ":"

Phrase: "Effects of natural free radical scavengers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "on peripheral nerve"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0031119:Peripheral nerve [Body Part, Organ, or Organ Component]
  1000   C1280200:Peripheral nerve [Body Part, Organ, or Organ Component]
   861   C0027740:Nerve [Tissue]
   861   C0027757:NERVE [Tissue]
   861   C0205100:Peripheral [Spatial Concept]
   861   C1280541:Nerve [Body Part, Organ, or Organ Component]
   805 E C0599851:Neural [Functional Concept]
   789 E C0027769:nervy [Sign or Symptom]

Phrase: "and"

Phrase: "neurovascular function in diabetic rats."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]
Processing 00000000.tx.190: Diabetologia 38:12851294, 1995[Medline] Koya D, Lee IK, Ishii H, Kanoh H, King GL: Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha tocopherol. 

Phrase: "Diabetologia 38"

Phrase: ":"

Phrase: "12851294,"

Phrase: "1995"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Koya D,"

Phrase: "Lee IK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1416378:IK [Gene or Genome]

Phrase: "Ishii H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kanoh H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "King"

Phrase: "GL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0018229:GL [Geographic Area]
  1000   C1423073:GL [Gene or Genome]
  1000   C1427674:GL [Gene or Genome]

Phrase: ":"

Phrase: "Prevention of glomerular dysfunction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0199176:Prevention [Therapeutic or Preventive Procedure]
   770   C1706420:PREVENTION [Research Activity]
   770   C2700409:prevention [Qualitative Concept]

Phrase: "in diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "by treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with d-alpha tocopherol."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0969677:d-alpha Tocopherol [Lipid,Organic Chemical,Pharmacologic Substance,Vitamin]
           .ALPHA.-Tocopherol
   901   C1142098:Alpha Tocopherol [Laboratory Procedure]
   827   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0087096:Tocopherol [Lipid,Pharmacologic Substance,Vitamin]
   827   C0439095:Alpha [Intellectual Product]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]
   827   C3255108:Tocopherol [Pharmacologic Substance]
Processing 00000000.tx.191: J Am Soc Nephrol 8:426435, 1997[Abstract] Palumbo EJ, Sweatt JD, Chen S-J, Klann E: Oxidation-induced persistent activation of protein kinase C in hippocampal homogenates. 

Phrase: "J"

Phrase: "Am"

Phrase: "Soc Nephrol 8"

Phrase: ":"

Phrase: "426435,"

Phrase: "1997"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Palumbo EJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1718783:Ej [Immunologic Factor]

Phrase: "Sweatt JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Chen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "S-"

Phrase: "J,"

Phrase: "Klann E"

Phrase: ":"

Phrase: "Oxidation-induced persistent activation of protein kinase C"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   822   C3546691:protein kinase C activation [Molecular Function]
   793   C1819041:protein kinase activation [Cell Function]
   767   C0599177:protein activation [Genetic Function]
   744   C1879547:Activation [Activity]

Phrase: "in hippocampal homogenates."
Processing 00000000.tx.192: Biochem Biophys Res Commun 187:14381445, 1992 Stauble B, Boscoboinik D, Tasinato A, Azzi A: Modulation of activator protein-1 (AP-1) transcription factor and protein kinase C by hydrogen peroxide and D--tocopherol in vascular smooth muscles. 

Phrase: "Biochem Biophys Res Commun 187"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "14381445,"

Phrase: "1992 Stauble B,"

Phrase: "Boscoboinik D,"

Phrase: "Tasinato A,"

Phrase: "Azzi A"

Phrase: ":"

Phrase: "Modulation of activator protein-1 (AP-1) transcription factor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0443264:Modulation [Spatial Concept]

Phrase: "and"

Phrase: "protein kinase C by hydrogen peroxide"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   820 E C1259877:kinase c protein [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   783   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   783   C1168438:Protein C [Laboratory Procedure]
   783   C1418943:PROTEIN C [Gene or Genome]
   783   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "D--"

Phrase: "tocopherol in vascular smooth muscles."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0087096:Tocopherol [Lipid,Pharmacologic Substance,Vitamin]
   760   C3255108:Tocopherol [Pharmacologic Substance]
Processing 00000000.tx.193: Eur J Biochem 226:393402, 1994[Abstract] Ha H, Yoon SJ, Kim KH: High glucose can induce lipid peroxidation in the isolated rat glomeruli. 

Phrase: "Eur J Biochem 226"

Phrase: ":"

Phrase: "393402,"

Phrase: "1994"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ha H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Yoon SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Kim KH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006797:KH [Geographic Area]

Phrase: ":"

Phrase: "High glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0860803:high glucose [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "can"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "lipid peroxidation in the isolated rat glomeruli."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0023775:Lipid Peroxidation [Molecular Function]
   748   C0023779:Lipid [Lipid]
   748   C0178796:peroxidation [Phenomenon or Process]
Processing 00000000.tx.194: Kidney Int 46:16201626, 1994[Medline] Kowluru RA, Engerman RL, Kern TS: Oxidative stress and protein kinase C are inter-related in retinas of diabetic rats and galactose-fed rats (Abstract). 

Phrase: "Kidney Int 46"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0022646:Kidney [Body Part, Organ, or Organ Component]
   827   C0063789:INT [Organic Chemical]
   827   C0227665:kidney [Body Part, Organ, or Organ Component]
   827   C1278978:Kidney [Body Part, Organ, or Organ Component]
   827   C1514845:KIDNEY [Tissue]
   827   C3272375:INT [Intellectual Product]
   734 E C0027697:Nephritides [Disease or Syndrome]

Phrase: ":"

Phrase: "16201626,"

Phrase: "1994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kowluru RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Engerman RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "Kern TS"

Phrase: ":"

Phrase: "Oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "protein kinase C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "inter-related in retinas of diabetic rats"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0205103:Inter- [Spatial Concept]
   748   C0439849:Related [Qualitative Concept]
   748   C0445223:Related [Finding]
   748   C1548610:Inter [Temporal Concept]
   714 E C0163712:Relate [Organic Chemical]

Phrase: "and"

Phrase: "galactose-fed rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]

Phrase: "(Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.195: Diabetes 46 (Suppl. 1):9A, 1997 Schreck R, Rieber P, Baeuerle PA: Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. 

Phrase: "Diabetes 46"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(Suppl. 1"

Phrase: ")"

Phrase: ":"

Phrase: "9A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553641:9a [Body Part, Organ, or Organ Component]

Phrase: "1997 Schreck R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "Rieber P,"

Phrase: "Baeuerle PA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: ":"

Phrase: "Reactive oxygen intermediates"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0920643:reactive oxygen intermediate [Biologically Active Substance]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   793   C0205103:Intermediate [Spatial Concept]
   793   C1550465:intermediate [Idea or Concept]
   793   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "as"

Phrase: "apparently widely used messengers in the activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0169911:messengers [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C0335218:messengers [Professional or Occupational Group]

Phrase: "of the NF-kappa B transcription factor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0040649:Transcription [Genetic Function]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   717   C0079904:NF-kappa B [Amino Acid, Peptide, or Protein,Immunologic Factor]
   717   C2986464:NF-kappa-B [Gene or Genome]

Phrase: "and"

Phrase: "HIV-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019704:HIV-1 [Virus]
   861   C0019682:HIV [Virus]
   861   C0019699:HIV+ [Finding]
Processing 00000000.tx.196: EMBO J 10:22472258, 1991[Abstract] Schrammel A, Koesling D, Schmidt K, Mayer B: Inhibition of purified soluble guanylyl cyclase by L-ascorbic acid. 

Phrase: "EMBO J 10"

Phrase: ":"

Phrase: "22472258,"

Phrase: "1991"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Schrammel A,"

Phrase: "Koesling D,"

Phrase: "Schmidt K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Mayer B"

Phrase: ":"

Phrase: "Inhibition of purified soluble guanylyl cyclase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "by L-ascorbic acid."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0003968:L-Ascorbic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
           Ascorbic Acid
   845 E C0699147:Cecon [Carbohydrate,Pharmacologic Substance,Vitamin]
   845 E C0699151:Cenolate [Carbohydrate,Pharmacologic Substance,Vitamin]
   845 E C0699153:Cevalin [Carbohydrate,Pharmacologic Substance,Vitamin]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
   817 E C2349136:Vitamin C [Organic Chemical,Vitamin]
Processing 00000000.tx.197: Cardiovasc Res 47:602608, 2000[Medline]

Phrase: "Cardiovasc Res 47"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "602608,"

Phrase: "2000"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

